Country Name,Country Code,Series Name,Series Code,2000 [YR2000],2001 [YR2001],2002 [YR2002],2003 [YR2003],2004 [YR2004],2005 [YR2005],2006 [YR2006],2007 [YR2007],2008 [YR2008],2009 [YR2009],2010 [YR2010],2011 [YR2011],2012 [YR2012],2013 [YR2013],2014 [YR2014],2015 [YR2015],2016 [YR2016],2017 [YR2017],2018 [YR2018],2019 [YR2019],2020 [YR2020],2021 [YR2021]
Afghanistan,AFG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,48.2096194,48.9028772,49.596135,50.3981522,51.2001694,52.0021866,52.8042038,53.606221,54.4434294,55.2806378,56.1178462,56.9550546,57.792263,58.423871,59.055479,59.687087,60.318695,60.950303,61.4942584,62.0382138,62.5821692,..
Afghanistan,AFG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,54.1338672,54.8533456,55.572824,56.429403,57.285982,58.142561,58.99914,59.855719,60.7424844,61.6292498,62.5160152,63.4027806,64.289546,64.946512,65.603478,66.260444,66.91741,67.574376,68.161778,68.74918,69.336582,..
Albania,ALB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,78.304781,79.202819,80.100857,80.29339,80.485923,80.678456,80.870989,81.063522,81.4146096,81.7656972,82.1167848,82.4678724,82.81896,83.1957256,83.5724912,83.9492568,84.3260224,84.702788,84.8943206,85.0858532,85.2773858,..
Albania,ALB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,87.62386,88.032359,88.440858,88.605522,88.770186,88.93485,89.099514,89.264178,89.609936,89.955694,90.301452,90.64721,90.992968,91.0234534,91.0539388,91.0844242,91.1149096,91.145395,91.2225726,91.2997502,91.3769278,..
Algeria,DZA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,72.9444058,73.7081814,74.471957,75.2699494,76.0679418,76.8659342,77.6639266,78.461919,78.858208,79.254497,79.650786,80.047075,80.443364,80.7325988,81.0218336,81.3110684,81.6003032,81.889538,82.1244132,82.3592884,82.5941636,..
Algeria,DZA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.6274082,79.2163646,79.805321,80.4139128,81.0225046,81.6310964,82.2396882,82.84828,83.1694998,83.4907196,83.8119394,84.1331592,84.454379,84.7293842,85.0043894,85.2793946,85.5543998,85.829405,86.0510094,86.2726138,86.4942182,..
Angola,AGO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,34.5373672,35.0034726,35.469578,36.525852,37.582126,38.6384,39.694674,40.750948,42.0637626,43.3765772,44.6893918,46.0022064,47.315021,47.9789558,48.6428906,49.3068254,49.9707602,50.634695,51.1369686,51.6392422,52.1415158,..
Angola,AGO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.4219222,44.1097596,44.797597,46.1644822,47.5313674,48.8982526,50.2651378,51.632023,53.2021724,54.7723218,56.3424712,57.9126206,59.48277,60.3193652,61.1559604,61.9925556,62.8291508,63.665746,64.186799,64.707852,65.228905,..
Antigua and Barbuda,ATG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,74.2963408,74.7468774,75.197414,75.6704974,76.1435808,76.6166642,77.0897476,77.562831,77.8183046,78.0737782,78.3292518,78.5847254,78.840199,79.1380638,79.4359286,79.7337934,80.0316582,80.329523,80.5200758,80.7106286,80.9011814,..
Antigua and Barbuda,ATG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.0313972,84.3742786,84.71716,84.9797006,85.2422412,85.5047818,85.7673224,86.029863,86.0901376,86.1504122,86.2106868,86.2709614,86.331236,86.3464152,86.3615944,86.3767736,86.3919528,86.407132,86.5828732,86.7586144,86.9343556,..
Argentina,ARG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,71.6045926,71.9414128,72.278233,72.5939744,72.9097158,73.2254572,73.5411986,73.85694,74.1528076,74.4486752,74.7445428,75.0404104,75.336278,75.6134452,75.8906124,76.1677796,76.4449468,76.722114,76.9832518,77.2443896,77.5055274,..
Argentina,ARG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.9392458,84.1379044,84.336563,84.520485,84.704407,84.888329,85.072251,85.256173,85.4267028,85.5972326,85.7677624,85.9382922,86.108822,86.2671692,86.4255164,86.5838636,86.7422108,86.900558,87.0438168,87.1870756,87.3303344,..
Armenia,ARM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,67.4730858,68.3697764,69.266467,69.2493838,69.2323006,69.2152174,69.1981342,69.181051,69.532983,69.884915,70.236847,70.588779,70.940711,71.2996732,71.6586354,72.0175976,72.3765598,72.735522,72.9891916,73.2428612,73.4965308,..
Armenia,ARM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.7266452,82.4674016,83.208158,83.3246414,83.4411248,83.5576082,83.6740916,83.790575,84.1840484,84.5775218,84.9709952,85.3644686,85.757942,86.2334166,86.7088912,87.1843658,87.6598404,88.135315,88.2750314,88.4147478,88.5544642,..
Australia,AUS,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.9463408,85.4081694,85.869998,86.1484436,86.4268892,86.7053348,86.9837804,87.262226,87.4604128,87.6585996,87.8567864,88.0549732,88.25316,88.4617664,88.6703728,88.8789792,89.0875856,89.296192,89.4942954,89.6923988,89.8905022,..
Australia,AUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.0841072,91.3093316,91.534556,91.6890052,91.8434544,91.9979036,92.1523528,92.306802,92.4045604,92.5023188,92.6000772,92.6978356,92.795594,92.928301,93.061008,93.193715,93.326422,93.459129,93.5613138,93.6634986,93.7656834,..
Austria,AUT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,80.9777176,81.4967128,82.015708,82.3394632,82.6632184,82.9869736,83.3107288,83.634484,83.9404668,84.2464496,84.5524324,84.8584152,85.164398,85.404899,85.6454,85.885901,86.126402,86.366903,86.5144186,86.6619342,86.8094498,..
Austria,AUT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.3517012,90.5471026,90.742504,90.9222246,91.1019452,91.2816658,91.4613864,91.641107,91.7274724,91.8138378,91.9002032,91.9865686,92.072934,92.1627908,92.2526476,92.3425044,92.4323612,92.522218,92.6650272,92.8078364,92.9506456,..
Azerbaijan,AZE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,62.5852844,63.5102882,64.435292,65.0804196,65.7255472,66.3706748,67.0158024,67.66093,68.2120964,68.7632628,69.3144292,69.8655956,70.416762,71.209068,72.001374,72.79368,73.585986,74.378292,74.527948,74.677604,74.82726,..
Azerbaijan,AZE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.3154014,76.4509942,76.586587,77.5153338,78.4440806,79.3728274,80.3015742,81.230321,81.539424,81.848527,82.15763,82.466733,82.775836,82.9828526,83.1898692,83.3968858,83.6039024,83.810919,83.9783186,84.1457182,84.3131178,..
"Bahamas, The",BHS,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,64.4495034,64.9573812,65.465259,65.8324172,66.1995754,66.5667336,66.9338918,67.30105,67.7022466,68.1034432,68.5046398,68.9058364,69.307033,69.852057,70.397081,70.942105,71.487129,72.032153,72.206665,72.381177,72.555689,..
"Bahamas, The",BHS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.112785,78.419035,78.725285,78.9294952,79.1337054,79.3379156,79.5421258,79.746336,79.9260174,80.1056988,80.2853802,80.4650616,80.644743,80.9725796,81.3004162,81.6282528,81.9560894,82.283926,82.4683624,82.6527988,82.8372352,..
Bahrain,BHR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,81.6832148,82.2778054,82.872396,83.130305,83.388214,83.646123,83.904032,84.161941,84.4040066,84.6460722,84.8881378,85.1302034,85.372269,85.5500764,85.7278838,85.9056912,86.0834986,86.261306,86.4268584,86.5924108,86.7579632,..
Bahrain,BHR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.8882254,85.2221022,85.555979,85.873391,86.190803,86.508215,86.825627,87.143039,87.3312438,87.5194486,87.7076534,87.8958582,88.084063,88.2657154,88.4473678,88.6290202,88.8106726,88.992325,89.1450618,89.2977986,89.4505354,..
Bangladesh,BGD,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,66.6014832,67.1314916,67.6615,68.1219062,68.5823124,69.0427186,69.5031248,69.963531,70.3720906,70.7806502,71.1892098,71.5977694,72.006329,72.2854146,72.5645002,72.8435858,73.1226714,73.401757,73.8115774,74.2213978,74.6312182,..
Bangladesh,BGD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.8277908,69.6255374,70.423284,71.132092,71.8409,72.549708,73.258516,73.967324,74.586759,75.206194,75.825629,76.445064,77.064499,77.4911494,77.9177998,78.3444502,78.7711006,79.197751,79.5995176,80.0012842,80.4030508,..
Barbados,BRB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.6723862,76.0910406,76.509695,76.8119988,77.1143026,77.4166064,77.7189102,78.021214,78.3207056,78.6201972,78.9196888,79.2191804,79.518672,79.6746522,79.8306324,79.9866126,80.1425928,80.298573,80.5085366,80.7185002,80.9284638,..
Barbados,BRB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.1624484,84.2359622,84.309476,84.4210422,84.5326084,84.6441746,84.7557408,84.867307,84.9502116,85.0331162,85.1160208,85.1989254,85.28183,85.3813936,85.4809572,85.5805208,85.6800844,85.779648,85.90178,86.023912,86.146044,..
Belarus,BLR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,50.5961328,50.5165414,50.43695,50.9780264,51.5191028,52.0601792,52.6012556,53.142332,54.5268106,55.9112892,57.2957678,58.6802464,60.064725,61.3982292,62.7317334,64.0652376,65.3987418,66.732246,67.1042564,67.4762668,67.8482772,..
Belarus,BLR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.1827924,79.2565192,79.330246,79.7872588,80.2442716,80.7012844,81.1582972,81.61531,82.3560634,83.0968168,83.8375702,84.5783236,85.319077,85.8408472,86.3626174,86.8843876,87.4061578,87.927928,88.064965,88.202002,88.339039,..
Belgium,BEL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,80.8265192,81.1136716,81.400824,81.7236462,82.0464684,82.3692906,82.6921128,83.014935,83.359634,83.704333,84.049032,84.393731,84.73843,84.9982084,85.2579868,85.5177652,85.7775436,86.037322,86.2686036,86.4998852,86.7311668,..
Belgium,BEL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.568754,89.694116,89.819478,89.9294194,90.0393608,90.1493022,90.2592436,90.369185,90.48243,90.595675,90.70892,90.822165,90.93541,91.0624592,91.1895084,91.3165576,91.4436068,91.570656,91.6810834,91.7915108,91.9019382,..
Belize,BLZ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.1455182,65.3438516,65.542185,65.745683,65.949181,66.152679,66.356177,66.559675,67.1832836,67.8068922,68.4305008,69.0541094,69.677718,69.7993136,69.9209092,70.0425048,70.1641004,70.285696,70.5138886,70.7420812,70.9702738,..
Belize,BLZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.0649856,77.2334888,77.401992,77.5677796,77.7335672,77.8993548,78.0651424,78.23093,78.5634408,78.8959516,79.2284624,79.5609732,79.893484,80.3139564,80.7344288,81.1549012,81.5753736,81.995846,82.1712418,82.3466376,82.5220334,..
Benin,BEN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,49.4091668,49.7502694,50.091372,50.8572162,51.6230604,52.3889046,53.1547488,53.920593,54.2979754,54.6753578,55.0527402,55.4301226,55.807505,56.1991798,56.5908546,56.9825294,57.3742042,57.765879,58.2126658,58.6594526,59.1062394,..
Benin,BEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.8270306,56.0205758,56.214121,56.8810236,57.5479262,58.2148288,58.8817314,59.548634,59.9402624,60.3318908,60.7235192,61.1151476,61.506776,61.9508874,62.3949988,62.8391102,63.2832216,63.727333,64.2169872,64.7066414,65.1962956,..
Bhutan,BTN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,56.5798168,57.8646644,59.149512,60.3198198,61.4901276,62.6604354,63.8307432,65.001051,65.7031784,66.4053058,67.1074332,67.8095606,68.511688,69.0262748,69.5408616,70.0554484,70.5700352,71.084622,71.4703702,71.8561184,72.2418666,..
Bhutan,BTN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.183474,57.503858,58.824242,59.9608192,61.0973964,62.2339736,63.3705508,64.507128,65.1105592,65.7139904,66.3174216,66.9208528,67.524284,68.1964664,68.8686488,69.5408312,70.2130136,70.885196,71.414696,71.944196,72.473696,..
Bolivia,BOL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,58.3396238,59.0310304,59.722437,60.3010882,60.8797394,61.4583906,62.0370418,62.615693,63.1359406,63.6561882,64.1764358,64.6966834,65.216931,65.5199404,65.8229498,66.1259592,66.4289686,66.731978,67.0747602,67.4175424,67.7603246,..
Bolivia,BOL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.843956,66.643622,67.443288,68.1173842,68.7914804,69.4655766,70.1396728,70.813769,71.4069106,72.0000522,72.5931938,73.1863354,73.779477,74.1798554,74.5802338,74.9806122,75.3809906,75.781369,76.1184064,76.4554438,76.7924812,..
Bosnia and Herzegovina,BIH,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,74.3660082,74.8518066,75.337605,75.6904278,76.0432506,76.3960734,76.7488962,77.101719,77.598488,78.095257,78.592026,79.088795,79.585564,79.7822968,79.9790296,80.1757624,80.3724952,80.569228,80.8347556,81.1002832,81.3658108,..
Bosnia and Herzegovina,BIH,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.5641686,85.9527998,86.341431,86.5118762,86.6823214,86.8527666,87.0232118,87.193657,87.5045348,87.8154126,88.1262904,88.4371682,88.748046,88.917573,89.0871,89.256627,89.426154,89.595681,89.7425306,89.8893802,90.0362298,..
Botswana,BWA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,27.0920058,26.2120084,25.332011,27.558983,29.785955,32.012927,34.239899,36.466871,39.939153,43.411435,46.883717,50.355999,53.828281,55.8257166,57.8231522,59.8205878,61.8180234,63.815459,64.0521396,64.2888202,64.5255008,..
Botswana,BWA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.7108356,38.3342678,36.9577,39.0614946,41.1652892,43.2690838,45.3728784,47.476673,51.1244968,54.7723206,58.4201444,62.0679682,65.715792,67.722395,69.728998,71.735601,73.742204,75.748807,76.0065802,76.2643534,76.5221266,..
Brazil,BRA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,64.9104174,65.4650722,66.019727,66.5470248,67.0743226,67.6016204,68.1289182,68.656216,69.1860488,69.7158816,70.2457144,70.7755472,71.30538,71.6245066,71.9436332,72.2627598,72.5818864,72.901013,73.2415578,73.5821026,73.9226474,..
Brazil,BRA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.8951482,79.4077356,79.920323,80.3516264,80.7829298,81.2142332,81.6455366,82.07684,82.3929576,82.7090752,83.0251928,83.3413104,83.657428,83.9189164,84.1804048,84.4418932,84.7033816,84.96487,85.1678924,85.3709148,85.5739372,..
Brunei Darussalam,BRN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.0750316,75.5108468,75.946662,76.161985,76.377308,76.592631,76.807954,77.023277,77.1022198,77.1811626,77.2601054,77.3390482,77.417991,77.5191812,77.6203714,77.7215616,77.8227518,77.923942,78.1299688,78.3359956,78.5420224,..
Brunei Darussalam,BRN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.0231706,82.3296278,82.636085,82.7681672,82.9002494,83.0323316,83.1644138,83.296496,83.395057,83.493618,83.592179,83.69074,83.789301,83.8677134,83.9461258,84.0245382,84.1029506,84.181363,84.3902656,84.5991682,84.8080708,..
Bulgaria,BGR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,66.1473888,66.5818164,67.016244,67.2904462,67.5646484,67.8388506,68.1130528,68.387255,68.8321976,69.2771402,69.7220828,70.1670254,70.611968,70.793881,70.975794,71.157707,71.33962,71.521533,71.7985414,72.0755498,72.3525582,..
Bulgaria,BGR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.7764944,84.0696692,84.362844,84.565565,84.768286,84.971007,85.173728,85.376449,85.5417354,85.7070218,85.8723082,86.0375946,86.202881,86.2686724,86.3344638,86.4002552,86.4660466,86.531838,86.6871608,86.8424836,86.9978064,..
Burkina Faso,BFA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,42.654247,43.299638,43.945029,45.1068394,46.2686498,47.4304602,48.5922706,49.754081,50.6754834,51.5968858,52.5182882,53.4396906,54.361093,54.9984604,55.6358278,56.2731952,56.9105626,57.54793,58.180973,58.814016,59.447059,..
Burkina Faso,BFA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,48.8783522,49.1830896,49.487827,50.3190202,51.1502134,51.9814066,52.8125998,53.643793,54.569029,55.494265,56.419501,57.344737,58.269973,59.0135844,59.7571958,60.5008072,61.2444186,61.98803,62.6870182,63.3860064,64.0849946,..
Burundi,BDI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,36.515659,37.818985,39.122311,40.6150872,42.1078634,43.6006396,45.0934158,46.586192,47.5359656,48.4857392,49.4355128,50.3852864,51.33506,51.9521898,52.5693196,53.1864494,53.8035792,54.420709,54.9498872,55.4790654,56.0082436,..
Burundi,BDI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.3440952,44.5865936,45.829092,47.2662854,48.7034788,50.1406722,51.5778656,53.015059,54.0938096,55.1725602,56.2513108,57.3300614,58.408812,59.0422542,59.6756964,60.3091386,60.9425808,61.576023,62.1553096,62.7345962,63.3138828,..
Cabo Verde,CPV,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,63.8278334,64.1694762,64.511119,64.756412,65.001705,65.246998,65.492291,65.737584,66.252668,66.767752,67.282836,67.79792,68.313004,68.8368744,69.3607448,69.8846152,70.4084856,70.932356,71.2138202,71.4952844,71.7767486,..
Cabo Verde,CPV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.6685668,79.0041884,80.33981,80.7156884,81.0915668,81.4674452,81.8433236,82.219202,82.454704,82.690206,82.925708,83.16121,83.396712,83.660124,83.923536,84.186948,84.45036,84.713772,84.9256352,85.1374984,85.3493616,..
Cambodia,KHM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,52.4514514,53.7490342,55.046617,56.3413548,57.6360926,58.9308304,60.2255682,61.520306,62.2470706,62.9738352,63.7005998,64.4273644,65.154129,65.6216458,66.0891626,66.5566794,67.0241962,67.491713,67.9075174,68.3233218,68.7391262,..
Cambodia,KHM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.251703,62.500578,63.749453,65.0569016,66.3643502,67.6717988,68.9792474,70.286696,71.0213126,71.7559292,72.4905458,73.2251624,73.959779,74.6110622,75.2623454,75.9136286,76.5649118,77.216195,77.592968,77.969741,78.346514,..
Cameroon,CMR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,39.9668412,40.0750176,40.183194,40.9990248,41.8148556,42.6306864,43.4465172,44.262348,44.9006912,45.5390344,46.1773776,46.8157208,47.454064,48.3449348,49.2358056,50.1266764,51.0175472,51.908418,52.3870352,52.8656524,53.3442696,..
Cameroon,CMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.3616742,46.0118316,45.661989,46.2030456,46.7441022,47.2851588,47.8262154,48.367272,49.3309218,50.2945716,51.2582214,52.2218712,53.185521,53.9576392,54.7297574,55.5018756,56.2739938,57.046112,57.588547,58.130982,58.673417,..
Canada,CAN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,83.777712,84.128463,84.479214,84.7480914,85.0169688,85.2858462,85.5547236,85.823601,86.1461852,86.4687694,86.7913536,87.1139378,87.436522,87.554987,87.673452,87.791917,87.910382,88.028847,88.2719362,88.5150254,88.7581146,..
Canada,CAN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.9812526,90.1336168,90.285981,90.4177182,90.5494554,90.6811926,90.8129298,90.944667,91.1181934,91.2917198,91.4652462,91.6387726,91.812299,91.8826254,91.9529518,92.0232782,92.0936046,92.163931,92.2575774,92.3512238,92.4448702,..
Central African Republic,CAF,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,26.530087,26.373158,26.216229,26.80895,27.401671,27.994392,28.587113,29.179834,30.0331838,30.8865336,31.7398834,32.5932332,33.446583,34.3124528,35.1783226,36.0441924,36.9100622,37.775932,38.25218,38.728428,39.204676,..
Central African Republic,CAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.5466596,31.7222238,30.897788,31.6815974,32.4654068,33.2492162,34.0330256,34.816835,35.848615,36.880395,37.912175,38.943955,39.975735,41.428307,42.880879,44.333451,45.786023,47.238595,47.7429616,48.2473282,48.7516948,..
Chad,TCD,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,37.4548222,37.4406706,37.426519,37.8429478,38.2593766,38.6758054,39.0922342,39.508663,40.1805316,40.8524002,41.5242688,42.1961374,42.868006,43.2756824,43.6833588,44.0910352,44.4987116,44.906388,45.2766954,45.6470028,46.0173102,..
Chad,TCD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.2227088,42.1594624,42.096216,42.49174,42.887264,43.282788,43.678312,44.073836,44.8768768,45.6799176,46.4829584,47.2859992,48.08904,48.5098724,48.9307048,49.3515372,49.7723696,50.193202,50.6082618,51.0233216,51.4383814,..
Chile,CHL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,77.3275298,77.7507484,78.173967,78.5587716,78.9435762,79.3283808,79.7131854,80.09799,80.4441606,80.7903312,81.1365018,81.4826724,81.828843,82.1370546,82.4452662,82.7534778,83.0616894,83.369901,83.652233,83.934565,84.216897,..
Chile,CHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,87.2776062,87.5626336,87.847661,88.0666284,88.2855958,88.5045632,88.7235306,88.942498,89.132558,89.322618,89.512678,89.702738,89.892798,89.9286714,89.9645448,90.0004182,90.0362916,90.072165,90.1646294,90.2570938,90.3495582,..
China,CHN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.890704,76.626658,77.362612,77.7312312,78.0998504,78.4684696,78.8370888,79.205708,79.5382404,79.8707728,80.2033052,80.5358376,80.86837,81.3018128,81.7352556,82.1686984,82.6021412,83.035584,83.2888436,83.5421032,83.7953628,..
China,CHN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.7062348,82.1256224,82.54501,83.005911,83.466812,83.927713,84.388614,84.849515,85.3211408,85.7927666,86.2643924,86.7360182,87.207644,87.5392486,87.8708532,88.2024578,88.5340624,88.865667,89.0280694,89.1904718,89.3528742,..
Colombia,COL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,71.0756946,71.6179938,72.160293,72.574488,72.988683,73.402878,73.817073,74.231268,74.6289796,75.0266912,75.4244028,75.8221144,76.219826,76.5559094,76.8919928,77.2280762,77.5641596,77.900243,78.161847,78.423451,78.685055,..
Colombia,COL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.6784384,83.0168362,83.355234,83.6214238,83.8876136,84.1538034,84.4199932,84.686183,84.9078444,85.1295058,85.3511672,85.5728286,85.79449,85.9984866,86.2024832,86.4064798,86.6104764,86.814473,86.9836638,87.1528546,87.3220454,..
Comoros,COM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,52.9163188,52.9985554,53.080792,53.4972724,53.9137528,54.3302332,54.7467136,55.163194,55.7766906,56.3901872,57.0036838,57.6171804,58.230677,58.5842678,58.9378586,59.2914494,59.6450402,59.998631,60.319789,60.640947,60.962105,..
Comoros,COM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.949012,60.0716,60.194188,60.6007694,61.0073508,61.4139322,61.8205136,62.227095,62.8698146,63.5125342,64.1552538,64.7979734,65.440693,65.850395,66.260097,66.669799,67.079501,67.489203,67.8592872,68.2293714,68.5994556,..
"Congo, Dem. Rep.",COD,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,42.077508,42.890837,43.704166,44.7553502,45.8065344,46.8577186,47.9089028,48.960087,49.7433818,50.5266766,51.3099714,52.0932662,52.876561,53.4918494,54.1071378,54.7224262,55.3377146,55.953003,56.3582606,56.7635182,57.1687758,..
"Congo, Dem. Rep.",COD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.7248302,48.5540246,49.383219,50.4407188,51.4982186,52.5557184,53.6132182,54.670718,55.4493906,56.2280632,57.0067358,57.7854084,58.564081,59.2330428,59.9020046,60.5709664,61.2399282,61.90889,62.3601988,62.8115076,63.2628164,..
"Congo, Rep.",COG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,38.996189,39.860584,40.724979,42.4439986,44.1630182,45.8820378,47.6010574,49.320077,50.6155124,51.9109478,53.2063832,54.5018186,55.797254,56.4269106,57.0565672,57.6862238,58.3158804,58.945537,59.2820262,59.6185154,59.9550046,..
"Congo, Rep.",COG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.4579568,44.6421354,44.826314,46.5212932,48.2162724,49.9112516,51.6062308,53.30121,54.665933,56.030656,57.395379,58.760102,60.124825,61.1139882,62.1031514,63.0923146,64.0814778,65.070641,65.4740832,65.8775254,66.2809676,..
Costa Rica,CRI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,80.2897062,80.4701656,80.650625,80.7730374,80.8954498,81.0178622,81.1402746,81.262687,81.4098072,81.5569274,81.7040476,81.8511678,81.998288,82.1601748,82.3220616,82.4839484,82.6458352,82.807722,83.0865958,83.3654696,83.6443434,..
Costa Rica,CRI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,87.6792644,87.8487932,88.018322,88.1373068,88.2562916,88.3752764,88.4942612,88.613246,88.7676436,88.9220412,89.0764388,89.2308364,89.385234,89.5576804,89.7301268,89.9025732,90.0750196,90.247466,90.3860216,90.5245772,90.6631328,..
Cote d'Ivoire,CIV,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,35.6409728,35.0081114,34.37525,35.1572136,35.9391772,36.7211408,37.5031044,38.285068,39.3524854,40.4199028,41.4873202,42.5547376,43.622155,44.4565442,45.2909334,46.1253226,46.9597118,47.794101,48.2634676,48.7328342,49.2022008,..
Cote d'Ivoire,CIV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.9144466,41.0991148,40.283783,40.9110732,41.5383634,42.1656536,42.7929438,43.420234,44.4003234,45.3804128,46.3605022,47.3405916,48.320681,49.2576886,50.1946962,51.1317038,52.0687114,53.005719,53.531259,54.056799,54.582339,..
Croatia,HRV,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,73.0169552,73.2133996,73.409844,73.9531708,74.4964976,75.0398244,75.5831512,76.126478,76.5396442,76.9528104,77.3659766,77.7791428,78.192309,78.6355786,79.0788482,79.5221178,79.9653874,80.408657,80.7134398,81.0182226,81.3230054,..
Croatia,HRV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,88.049033,88.133434,88.217835,88.4655838,88.7133326,88.9610814,89.2088302,89.456579,89.6214672,89.7863554,89.9512436,90.1161318,90.28102,90.4778422,90.6746644,90.8714866,91.0683088,91.265131,91.3930708,91.5210106,91.6489504,..
Cuba,CUB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,79.5696922,79.8818156,80.193939,80.4137518,80.6335646,80.8533774,81.0731902,81.293003,81.3917598,81.4905166,81.5892734,81.6880302,81.786787,81.8393658,81.8919446,81.9445234,81.9971022,82.049681,82.2013494,82.3530178,82.5046862,..
Cuba,CUB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.885916,86.125667,86.365418,86.521177,86.676936,86.832695,86.988454,87.144213,87.205213,87.266213,87.327213,87.388213,87.449213,87.4989954,87.5487778,87.5985602,87.6483426,87.698125,87.8023552,87.9065854,88.0108156,..
Cyprus,CYP,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.6330158,84.8577564,85.082497,85.2879154,85.4933338,85.6987522,85.9041706,86.109589,86.3603498,86.6111106,86.8618714,87.1126322,87.363393,87.6248394,87.8862858,88.1477322,88.4091786,88.670625,88.8766982,89.0827714,89.2888446,..
Cyprus,CYP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.2490436,91.4088998,91.568756,91.7110956,91.8534352,91.9957748,92.1381144,92.280454,92.4841226,92.6877912,92.8914598,93.0951284,93.298797,93.3945096,93.4902222,93.5859348,93.6816474,93.77736,93.8679776,93.9585952,94.0492128,..
Czechia,CZE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,73.4770808,74.0832024,74.689324,75.210013,75.730702,76.251391,76.77208,77.292769,77.8472542,78.4017394,78.9562246,79.5107098,80.065195,80.5642632,81.0633314,81.5623996,82.0614678,82.560536,82.8136206,83.0667052,83.3197898,..
Czechia,CZE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,87.6056306,87.8672788,88.128927,88.3720372,88.6151474,88.8582576,89.1013678,89.344478,89.5829966,89.8215152,90.0600338,90.2985524,90.537071,90.6532024,90.7693338,90.8854652,91.0015966,91.117728,91.2356564,91.3535848,91.4715132,..
Denmark,DNK,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,80.231975,80.690759,81.149543,81.468019,81.786495,82.104971,82.423447,82.741923,83.2431406,83.7443582,84.2455758,84.7467934,85.248011,85.4019946,85.5559782,85.7099618,85.8639454,86.017929,86.2387084,86.4594878,86.6802672,..
Denmark,DNK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,86.9859698,87.3755394,87.765109,88.0201276,88.2751462,88.5301648,88.7851834,89.040202,89.3510794,89.6619568,89.9728342,90.2837116,90.594589,90.6957992,90.7970094,90.8982196,90.9994298,91.10064,91.2138468,91.3270536,91.4402604,..
Djibouti,DJI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,49.5573268,49.6069684,49.65661,50.316842,50.977074,51.637306,52.297538,52.95777,53.7881154,54.6184608,55.4488062,56.2791516,57.109497,58.4864324,59.8633678,61.2403032,62.6172386,63.994174,64.39315,64.792126,65.191102,..
Djibouti,DJI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.7311964,55.6142742,55.497352,56.1334068,56.7694616,57.4055164,58.0415712,58.677626,59.5746006,60.4715752,61.3685498,62.2655244,63.162499,64.849553,66.536607,68.223661,69.910715,71.597769,72.050411,72.503053,72.955695,..
Dominican Republic,DOM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.4969368,65.7669654,66.036994,66.397249,66.757504,67.117759,67.478014,67.838269,68.1481034,68.4579378,68.7677722,69.0776066,69.387441,69.6858124,69.9841838,70.2825552,70.5809266,70.879298,71.122995,71.366692,71.610389,..
Dominican Republic,DOM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.0672012,76.4447236,76.822246,77.176527,77.530808,77.885089,78.23937,78.593651,78.8734088,79.1531666,79.4329244,79.7126822,79.99244,80.2604,80.52836,80.79632,81.06428,81.33224,81.5210248,81.7098096,81.8985944,..
Ecuador,ECU,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,70.9633918,71.3399144,71.716437,72.0473896,72.3783422,72.7092948,73.0402474,73.3712,73.7411954,74.1111908,74.4811862,74.8511816,75.221177,75.5977174,75.9742578,76.3507982,76.7273386,77.103879,77.4120342,77.7201894,78.0283446,..
Ecuador,ECU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.6930792,81.1120516,81.531024,81.7983706,82.0657172,82.3330638,82.6004104,82.867757,83.0968782,83.3259994,83.5551206,83.7842418,84.013363,84.3203596,84.6273562,84.9343528,85.2413494,85.548346,85.7505808,85.9528156,86.1550504,..
"Egypt, Arab Rep.",EGY,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.2757982,65.5367486,65.797699,66.1114696,66.4252402,66.7390108,67.0527814,67.366552,67.745709,68.124866,68.504023,68.88318,69.262337,69.544169,69.826001,70.107833,70.389665,70.671497,70.9378204,71.2041438,71.4704672,..
"Egypt, Arab Rep.",EGY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.1780164,76.4275632,76.67711,76.8862474,77.0953848,77.3045222,77.5136596,77.722797,78.0385198,78.3542426,78.6699654,78.9856882,79.301411,79.649061,79.996711,80.344361,80.692011,81.039661,81.3074496,81.5752382,81.8430268,..
El Salvador,SLV,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,60.1196116,60.4856438,60.851676,61.1316464,61.4116168,61.6915872,61.9715576,62.251528,62.5631162,62.8747044,63.1862926,63.4978808,63.809469,64.1117888,64.4141086,64.7164284,65.0187482,65.321068,65.7005242,66.0799804,66.4594366,..
El Salvador,SLV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.4205282,78.8082176,79.195907,79.4724078,79.7489086,80.0254094,80.3019102,80.578411,80.8797956,81.1811802,81.4825648,81.7839494,82.085334,82.3824088,82.6794836,82.9765584,83.2736332,83.570708,83.8133372,84.0559664,84.2985956,..
Equatorial Guinea,GNQ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,45.263638,45.6804,46.097162,46.2330042,46.3688464,46.5046886,46.6405308,46.776373,47.1114502,47.4465274,47.7816046,48.1166818,48.451759,48.8611798,49.2706006,49.6800214,50.0894422,50.498863,50.9851966,51.4715302,51.9578638,..
Equatorial Guinea,GNQ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.7438072,51.0254406,51.307074,51.3566976,51.4063212,51.4559448,51.5055684,51.555192,52.0612926,52.5673932,53.0734938,53.5795944,54.085695,54.4088864,54.7320778,55.0552692,55.3784606,55.701652,56.2481418,56.7946316,57.3411214,..
Eritrea,ERI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,44.0057466,44.1526338,44.299521,45.5913024,46.8830838,48.1748652,49.4666466,50.758428,51.5332256,52.3080232,53.0828208,53.8576184,54.632416,55.3961882,56.1599604,56.9237326,57.6875048,58.451277,59.0273794,59.6034818,60.1795842,..
Eritrea,ERI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,51.8769808,52.5642784,53.251576,54.3590424,55.4665088,56.5739752,57.6814416,58.788908,59.7658532,60.7427984,61.7197436,62.6966888,63.673634,64.5095528,65.3454716,66.1813904,67.0173092,67.853228,68.4670766,69.0809252,69.6947738,..
Estonia,EST,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,56.4066018,57.4836884,58.560775,59.6047586,60.6487422,61.6927258,62.7367094,63.780693,65.4274412,67.0741894,68.7209376,70.3676858,72.014434,72.902948,73.791462,74.679976,75.56849,76.457004,76.7958396,77.1346752,77.4735108,..
Estonia,EST,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.603289,83.090695,83.578101,84.107669,84.637237,85.166805,85.696373,86.225941,86.8540704,87.4821998,88.1103292,88.7384586,89.366588,89.643494,89.9204,90.197306,90.474212,90.751118,90.8658448,90.9805716,91.0952984,..
Eswatini,SWZ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,22.4617338,19.4800704,16.498407,16.3876102,16.2768134,16.1660166,16.0552198,15.944423,17.3996258,18.8548286,20.3100314,21.7652342,23.220437,26.3611362,29.5018354,32.6425346,35.7832338,38.923933,39.5870666,40.2502002,40.9133338,..
Eswatini,SWZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.6861776,31.3956758,27.105174,26.7252758,26.3453776,25.9654794,25.5855812,25.205683,27.7278404,30.2499978,32.7721552,35.2943126,37.81647,42.0731408,46.3298116,50.5864824,54.8431532,59.099824,59.7425638,60.3853036,61.0280434,..
Ethiopia,ETH,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,42.1976206,42.8747558,43.551891,45.3093486,47.0668062,48.8242638,50.5817214,52.339179,53.845488,55.351797,56.858106,58.364415,59.870724,60.5543568,61.2379896,61.9216224,62.6052552,63.288888,63.8354848,64.3820816,64.9286784,..
Ethiopia,ETH,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.393535,47.917808,48.442081,50.3589882,52.2758954,54.1928026,56.1097098,58.026617,59.745953,61.465289,63.184625,64.903961,66.623297,67.3747876,68.1262782,68.8777688,69.6292594,70.38075,70.9760526,71.5713552,72.1666578,..
Fiji,FJI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,59.0894322,59.5022006,59.914969,59.9958426,60.0767162,60.1575898,60.2384634,60.319337,60.5986346,60.8779322,61.1572298,61.4365274,61.715825,61.7929914,61.8701578,61.9473242,62.0244906,62.101657,62.2503746,62.3990922,62.5478098,..
Fiji,FJI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.841782,70.014631,70.18748,70.1835916,70.1797032,70.1758148,70.1719264,70.168038,70.4500006,70.7319632,71.0139258,71.2958884,71.577851,71.7867128,71.9955746,72.2044364,72.4132982,72.62216,72.9378194,73.2534788,73.5691382,..
Finland,FIN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,79.1214808,79.5310774,79.940674,80.1430768,80.3454796,80.5478824,80.7502852,80.952688,81.5169234,82.0811588,82.6453942,83.2096296,83.773865,84.0331534,84.2924418,84.5517302,84.8110186,85.070307,85.3415178,85.6127286,85.8839394,..
Finland,FIN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.5590006,90.6489948,90.738989,90.8353344,90.9316798,91.0280252,91.1243706,91.220716,91.4209608,91.6212056,91.8214504,92.0216952,92.22194,92.3542506,92.4865612,92.6188718,92.7511824,92.883493,92.9889004,93.0943078,93.1997152,..
France,FRA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,79.7374344,80.1422262,80.547018,80.9052142,81.2634104,81.6216066,81.9798028,82.337999,82.6347206,82.9314422,83.2281638,83.5248854,83.821607,84.0354452,84.2492834,84.4631216,84.6769598,84.890798,85.101314,85.31183,85.522346,..
France,FRA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.7691616,90.8974848,91.025808,91.146026,91.266244,91.386462,91.50668,91.626898,91.7271634,91.8274288,91.9276942,92.0279596,92.128225,92.1713104,92.2143958,92.2574812,92.3005666,92.343652,92.4187036,92.4937552,92.5688068,..
Gabon,GAB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,50.4073936,49.4337428,48.460092,49.2142536,49.9684152,50.7225768,51.4767384,52.2309,53.590728,54.950556,56.310384,57.670212,59.03004,59.8399636,60.6498872,61.4598108,62.2697344,63.079658,63.3822852,63.6849124,63.9875396,..
Gabon,GAB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.5240692,54.7127196,53.90137,54.5682694,55.2351688,55.9020682,56.5689676,57.235867,58.6849998,60.1341326,61.5832654,63.0323982,64.481531,65.8323006,67.1830702,68.5338398,69.8846094,71.235379,71.580687,71.925995,72.271303,..
"Gambia, The",GMB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,49.2993474,49.8660572,50.432767,50.8807448,51.3287226,51.7767004,52.2246782,52.672656,53.0869458,53.5012356,53.9155254,54.3298152,54.744105,55.0968524,55.4495998,55.8023472,56.1550946,56.507842,57.0530208,57.5981996,58.1433784,..
"Gambia, The",GMB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.3326648,55.8023404,56.272016,56.8679426,57.4638692,58.0597958,58.6557224,59.251649,59.6977924,60.1439358,60.5900792,61.0362226,61.482366,61.9131992,62.3440324,62.7748656,63.2056988,63.636532,64.2257536,64.8149752,65.4041968,..
Georgia,GEO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,64.0405154,64.5403122,65.040109,64.7129998,64.3858906,64.0587814,63.7316722,63.404563,63.7159784,64.0273938,64.3388092,64.6502246,64.96164,65.4506814,65.9397228,66.4287642,66.9178056,67.406847,67.715131,68.023415,68.331699,..
Georgia,GEO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.6098144,81.8121802,82.014546,82.3854266,82.7563072,83.1271878,83.4980684,83.868949,84.2062724,84.5435958,84.8809192,85.2182426,85.555566,85.8512846,86.1470032,86.4427218,86.7384404,87.034159,87.1896954,87.3452318,87.5007682,..
Germany,DEU,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,80.6842262,81.1809236,81.677621,82.0288608,82.3801006,82.7313404,83.0825802,83.43382,83.6721208,83.9104216,84.1487224,84.3870232,84.625324,84.7284688,84.8316136,84.9347584,85.0379032,85.141048,85.4444144,85.7477808,86.0511472,..
Germany,DEU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.0142138,90.2249214,90.435629,90.5679772,90.7003254,90.8326736,90.9650218,91.09737,91.176483,91.255596,91.334709,91.413822,91.492935,91.6233514,91.7537678,91.8841842,92.0146006,92.145017,92.300414,92.455811,92.611208,..
Ghana,GHA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,51.053354,51.116429,51.179504,52.066441,52.953378,53.840315,54.727252,55.614189,56.0617256,56.5092622,56.9567988,57.4043354,57.851872,58.3589296,58.8659872,59.3730448,59.8801024,60.38716,60.7848142,61.1824684,61.5801226,..
Ghana,GHA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.828832,55.890723,55.952614,56.8992302,57.8458464,58.7924626,59.7390788,60.685695,61.1394208,61.5931466,62.0468724,62.5005982,62.954324,63.5739886,64.1936532,64.8133178,65.4329824,66.052647,66.5222738,66.9919006,67.4615274,..
Greece,GRC,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,82.515442,82.740463,82.965484,83.0685768,83.1716696,83.2747624,83.3778552,83.480948,83.6835938,83.8862396,84.0888854,84.2915312,84.494177,84.6286922,84.7632074,84.8977226,85.0322378,85.166753,85.4277904,85.6888278,85.9498652,..
Greece,GRC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.940128,92.111773,92.283418,92.3587704,92.4341228,92.5094752,92.5848276,92.66018,92.724349,92.788518,92.852687,92.916856,92.981025,93.0420884,93.1031518,93.1642152,93.2252786,93.286342,93.3754178,93.4644936,93.5535694,..
Grenada,GRD,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,71.6562392,72.0430086,72.429778,72.5131692,72.5965604,72.6799516,72.7633428,72.846734,72.718297,72.58986,72.461423,72.332986,72.204549,72.1608828,72.1172166,72.0735504,72.0298842,71.986218,72.0488088,72.1113996,72.1739904,..
Grenada,GRD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.6442078,81.9305714,82.216935,82.2212438,82.2255526,82.2298614,82.2341702,82.238479,82.0816168,81.9247546,81.7678924,81.6110302,81.454168,81.4120544,81.3699408,81.3278272,81.2857136,81.2436,81.3073608,81.3711216,81.4348824,..
Guatemala,GTM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,62.4249326,63.1500848,63.875237,64.3133542,64.7514714,65.1895886,65.6277058,66.065823,66.6789678,67.2921126,67.9052574,68.5184022,69.131547,69.648152,70.164757,70.681362,71.197967,71.714572,72.049248,72.383924,72.7186,..
Guatemala,GTM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,74.6866432,75.3002896,75.913936,76.322694,76.731452,77.14021,77.548968,77.957726,78.4560146,78.9543032,79.4525918,79.9508804,80.449169,80.7395496,81.0299302,81.3203108,81.6106914,81.901072,82.1777868,82.4545016,82.7312164,..
Guinea,GIN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,45.5381298,45.1163484,44.694567,45.5406416,46.3867162,47.2327908,48.0788654,48.92494,49.8188538,50.7127676,51.6066814,52.5005952,53.394509,54.2735166,55.1525242,56.0315318,56.9105394,57.789547,58.2662692,58.7429914,59.2197136,..
Guinea,GIN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.4637002,46.9520686,46.440437,47.9429454,49.4454538,50.9479622,52.4504706,53.952979,54.4965986,55.0402182,55.5838378,56.1274574,56.671077,57.6744708,58.6778646,59.6812584,60.6846522,61.688046,62.242623,62.7972,63.351777,..
Guinea-Bissau,GNB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,38.0332238,38.5383764,39.043529,39.359092,39.674655,39.990218,40.305781,40.621344,41.264522,41.9077,42.550878,43.194056,43.837234,44.4109192,44.9846044,45.5582896,46.1319748,46.70566,47.2147998,47.7239396,48.2330794,..
Guinea-Bissau,GNB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.0483358,49.2475484,49.446761,49.6388456,49.8309302,50.0230148,50.2150994,50.407184,51.1313616,51.8555392,52.5797168,53.3038944,54.028072,54.3338838,54.6396956,54.9455074,55.2513192,55.557131,56.1074302,56.6577294,57.2080286,..
Guyana,GUY,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,56.0730752,55.8444766,55.615878,56.0731276,56.5303772,56.9876268,57.4448764,57.902126,58.321222,58.740318,59.159414,59.57851,59.997606,60.373273,60.74894,61.124607,61.500274,61.875941,62.0222668,62.1685926,62.3149184,..
Guyana,GUY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.1774574,69.0164532,68.855449,69.2837836,69.7121182,70.1404528,70.5687874,70.997122,71.372452,71.747782,72.123112,72.498442,72.873772,73.0583862,73.2430004,73.4276146,73.6122288,73.796843,73.9852224,74.1736018,74.3619812,..
Haiti,HTI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,49.3814944,49.6620302,49.942566,50.599382,51.256198,51.913014,52.56983,53.226646,53.804448,54.38225,54.960052,55.537854,56.115656,56.7673738,57.4190916,58.0708094,58.7225272,59.374245,59.795671,60.217097,60.638523,..
Haiti,HTI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.795907,57.07101,57.346113,58.0352188,58.7243246,59.4134304,60.1025362,60.791642,61.4123768,62.0331116,62.6538464,63.2745812,63.895316,64.5302246,65.1651332,65.8000418,66.4349504,67.069859,67.5225026,67.9751462,68.4277898,..
Honduras,HND,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,69.2307482,69.6602796,70.089811,70.4590442,70.8282774,71.1975106,71.5667438,71.935977,72.2778034,72.6196298,72.9614562,73.3032826,73.645109,73.9542962,74.2634834,74.5726706,74.8818578,75.191045,75.4468176,75.7025902,75.9583628,..
Honduras,HND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.9230168,77.2665594,77.610102,77.94604,78.281978,78.617916,78.953854,79.289792,79.6104686,79.9311452,80.2518218,80.5724984,80.893175,81.1361862,81.3791974,81.6222086,81.8652198,82.108231,82.3210348,82.5338386,82.7466424,..
Hungary,HUN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,61.7567304,62.5663392,63.375948,63.826196,64.276444,64.726692,65.17694,65.627188,66.5517132,67.4762384,68.4007636,69.3252888,70.249814,70.8390166,71.4282192,72.0174218,72.6066244,73.195827,73.5097468,73.8236666,74.1375864,..
Hungary,HUN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.4310894,82.8076112,83.184133,83.4021298,83.6201266,83.8381234,84.0561202,84.274117,84.5584364,84.8427558,85.1270752,85.4113946,85.695714,85.9970702,86.2984264,86.5997826,86.9011388,87.202495,87.3456266,87.4887582,87.6318898,..
Iceland,ISL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,86.4254522,86.8919396,87.358427,87.599296,87.840165,88.081034,88.321903,88.562772,88.8269948,89.0912176,89.3554404,89.6196632,89.883886,90.0418754,90.1998648,90.3578542,90.5158436,90.673833,90.8816552,91.0894774,91.2972996,..
Iceland,ISL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.9377616,91.1717138,91.405666,91.6611486,91.9166312,92.1721138,92.4275964,92.683079,92.7574646,92.8318502,92.9062358,92.9806214,93.055007,93.1570676,93.2591282,93.3611888,93.4632494,93.56531,93.7052694,93.8452288,93.9851882,..
India,IND,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,58.7756318,59.3845554,59.993479,60.6065932,61.2197074,61.8328216,62.4459358,63.05905,63.6433408,64.2276316,64.8119224,65.3962132,65.980504,66.4265808,66.8726576,67.3187344,67.7648112,68.210888,68.5568896,68.9028912,69.2488928,..
India,IND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.6482526,65.2479538,65.847655,66.4197816,66.9919082,67.5640348,68.1361614,68.708288,69.4066532,70.1050184,70.8033836,71.5017488,72.200114,72.6018084,73.0035028,73.4051972,73.8068916,74.208586,74.5944894,74.9803928,75.3662962,..
Indonesia,IDN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,64.1683248,64.3274384,64.486552,64.964118,65.441684,65.91925,66.396816,66.874382,67.3361226,67.7978632,68.2596038,68.7213444,69.183085,69.579878,69.976671,70.373464,70.770257,71.16705,71.4542978,71.7415456,72.0287934,..
Indonesia,IDN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,70.6183372,70.9482826,71.278228,71.895028,72.511828,73.128628,73.745428,74.362228,74.9308286,75.4994292,76.0680298,76.6366304,77.205231,77.6356866,78.0661422,78.4965978,78.9270534,79.357509,79.6647694,79.9720298,80.2792902,..
"Iran, Islamic Rep.",IRN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,73.1241572,73.6238196,74.123482,74.4256116,74.7277412,75.0298708,75.3320004,75.63413,77.0092496,78.3843692,79.7594888,81.1346084,82.509728,83.1090012,83.7082744,84.3075476,84.9068208,85.506094,85.759178,86.012262,86.265346,..
"Iran, Islamic Rep.",IRN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.8574674,78.7363232,79.615179,80.3562982,81.0974174,81.8385366,82.5796558,83.320775,84.1052104,84.8896458,85.6740812,86.4585166,87.242952,87.741789,88.240626,88.739463,89.2383,89.737137,89.9502738,90.1634106,90.3765474,..
Iraq,IRQ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,67.6648726,67.4567198,67.248567,66.4244354,65.6003038,64.7761722,63.9520406,63.127909,64.0741688,65.0204286,65.9666884,66.9129482,67.859208,68.2720132,68.6848184,69.0976236,69.5104288,69.923234,70.137262,70.35129,70.565318,..
Iraq,IRQ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.4296434,77.0606192,76.691595,76.7513028,76.8110106,76.8707184,76.9304262,76.990134,77.0570256,77.1239172,77.1908088,77.2577004,77.324592,77.5579304,77.7912688,78.0246072,78.2579456,78.491284,78.7386294,78.9859748,79.2333202,..
Ireland,IRL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,81.8048014,82.3623702,82.919939,83.4438474,83.9677558,84.4916642,85.0155726,85.539481,85.8203282,86.1011754,86.3820226,86.6628698,86.943717,87.284818,87.625919,87.96702,88.308121,88.649222,89.0136442,89.3780664,89.7424886,..
Ireland,IRL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.069377,89.362568,89.655759,89.9063432,90.1569274,90.4075116,90.6580958,90.90868,91.0139688,91.1192576,91.2245464,91.3298352,91.435124,91.6174632,91.7998024,91.9821416,92.1644808,92.34682,92.5900864,92.8333528,93.0766192,..
Israel,ISR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.1286374,84.4863882,84.844139,85.2341572,85.6241754,86.0141936,86.4042118,86.79423,87.0183854,87.2425408,87.4666962,87.6908516,87.915007,88.2102452,88.5054834,88.8007216,89.0959598,89.391198,89.6034966,89.8157952,90.0280938,..
Israel,ISR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.5788724,90.8557902,91.132708,91.3403744,91.5480408,91.7557072,91.9633736,92.17104,92.317585,92.46413,92.610675,92.75722,92.903765,93.0392436,93.1747222,93.3102008,93.4456794,93.581158,93.6801584,93.7791588,93.8781592,..
Italy,ITA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.080415,84.602002,85.123589,85.5091612,85.8947334,86.2803056,86.6658778,87.05145,87.3392128,87.6269756,87.9147384,88.2025012,88.490264,88.7682344,89.0462048,89.3241752,89.6021456,89.880116,90.0706176,90.2611192,90.4516208,..
Italy,ITA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.7492284,91.9680922,92.186956,92.3463948,92.5058336,92.6652724,92.8247112,92.98415,93.0794386,93.1747272,93.2700158,93.3653044,93.460593,93.5640754,93.6675578,93.7710402,93.8745226,93.978005,94.0796028,94.1812006,94.2827984,..
Jamaica,JAM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.8545094,76.3512872,76.848065,76.7593694,76.6706738,76.5819782,76.4932826,76.404587,75.9293802,75.4541734,74.9789666,74.5037598,74.028553,73.9787788,73.9290046,73.8792304,73.8294562,73.779682,73.9118958,74.0441096,74.1763234,..
Jamaica,JAM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.9035482,81.9965556,82.089563,82.2797428,82.4699226,82.6601024,82.8502822,83.040462,82.9289662,82.8174704,82.7059746,82.5944788,82.482983,82.5869004,82.6908178,82.7947352,82.8986526,83.00257,83.1919358,83.3813016,83.5706674,..
Japan,JPN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.8425194,85.0897422,85.336965,85.5644128,85.7918606,86.0193084,86.2467562,86.474204,86.7437428,87.0132816,87.2828204,87.5523592,87.821898,88.077893,88.333888,88.589883,88.845878,89.101873,89.2350102,89.3681474,89.5012846,..
Japan,JPN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,92.6236768,92.7739554,92.924234,93.0223108,93.1203876,93.2184644,93.3165412,93.414618,93.4835442,93.5524704,93.6213966,93.6903228,93.759249,93.8960564,94.0328638,94.1696712,94.3064786,94.443286,94.5306804,94.6180748,94.7054692,..
Jordan,JOR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,74.5415104,74.8486032,75.155696,75.4345238,75.7133516,75.9921794,76.2710072,76.549835,76.773958,76.998081,77.222204,77.446327,77.67045,77.8433656,78.0162812,78.1891968,78.3621124,78.535028,78.7369072,78.9387864,79.1406656,..
Jordan,JOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.472102,80.789531,81.10696,81.3884764,81.6699928,81.9515092,82.2330256,82.514542,82.7554582,82.9963744,83.2372906,83.4782068,83.719123,83.9188594,84.1185958,84.3183322,84.5180686,84.717805,84.9106818,85.1035586,85.2964354,..
Kazakhstan,KAZ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,44.3225368,44.8337124,45.344888,46.1125268,46.8801656,47.6478044,48.4154432,49.183082,50.7863688,52.3896556,53.9929424,55.5962292,57.199516,59.2000152,61.2005144,63.2010136,65.2015128,67.202012,67.4915984,67.7811848,68.0707712,..
Kazakhstan,KAZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.3380654,72.8712172,73.404369,73.8975856,74.3908022,74.8840188,75.3772354,75.870452,76.6842458,77.4980396,78.3118334,79.1256272,79.939421,80.9178756,81.8963302,82.8747848,83.8532394,84.831694,84.9992988,85.1669036,85.3345084,..
Kenya,KEN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,33.3321714,33.2397022,33.147233,36.0915402,39.0358474,41.9801546,44.9244618,47.868769,49.3011628,50.7335566,52.1659504,53.5983442,55.030738,56.1624778,57.2942176,58.4259574,59.5576972,60.689437,61.1056284,61.5218198,61.9380112,..
Kenya,KEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.2040262,42.7755046,42.346983,44.9827202,47.6184574,50.2541946,52.8899318,55.525669,57.3086542,59.0916394,60.8746246,62.6576098,64.440595,65.6565528,66.8725106,68.0884684,69.3044262,70.520384,70.9704974,71.4206108,71.8707242,..
Kiribati,KIR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,57.1866204,57.6369642,58.087308,58.2263156,58.3653232,58.5043308,58.6433384,58.782346,59.0446602,59.3069744,59.5692886,59.8316028,60.093917,60.4854782,60.8770394,61.2686006,61.6601618,62.051723,62.4137792,62.7758354,63.1378916,..
Kiribati,KIR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.3386592,68.8002056,69.261752,69.580348,69.898944,70.21754,70.536136,70.854732,71.2665154,71.6782988,72.0900822,72.5018656,72.913649,73.2342024,73.5547558,73.8753092,74.1958626,74.516416,74.8477898,75.1791636,75.5105374,..
"Korea, Dem. People's Rep.",PRK,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,59.106583,60.76687,62.427157,62.6881688,62.9491806,63.2101924,63.4712042,63.732216,64.6564848,65.5807536,66.5050224,67.4292912,68.35356,68.7452696,69.1369792,69.5286888,69.9203984,70.312108,70.6778152,71.0435224,71.4092296,..
"Korea, Dem. People's Rep.",PRK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,74.6633942,75.6812846,76.699175,76.799992,76.900809,77.001626,77.102443,77.20326,77.892596,78.581932,79.271268,79.960604,80.64994,81.0118004,81.3736608,81.7355212,82.0973816,82.459242,82.7255346,82.9918272,83.2581198,..
"Korea, Rep.",KOR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.8496606,76.9405238,78.031387,78.9498684,79.8683498,80.7868312,81.7053126,82.623794,83.1595018,83.6952096,84.2309174,84.7666252,85.302333,85.809883,86.317433,86.824983,87.332533,87.840083,88.0319274,88.2237718,88.4156162,..
"Korea, Rep.",KOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.8674732,90.3854336,90.903394,91.2473844,91.5913748,91.9353652,92.2793556,92.623346,92.8701232,93.1169004,93.3636776,93.6104548,93.857232,94.083705,94.310178,94.536651,94.763124,94.989597,95.0817362,95.1738754,95.2660146,..
Kuwait,KWT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,80.8028454,81.0453552,81.287865,81.645759,82.003653,82.361547,82.719441,83.077335,83.5221786,83.9670222,84.4118658,84.8567094,85.301553,85.5965432,85.8915334,86.1865236,86.4815138,86.776504,86.910626,87.044748,87.17887,..
Kuwait,KWT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.5811768,85.7701994,85.959222,86.1824772,86.4057324,86.6289876,86.8522428,87.075498,87.424816,87.774134,88.123452,88.47277,88.822088,89.0204184,89.2187488,89.4170792,89.6154096,89.81374,89.9806724,90.1476048,90.3145372,..
Kyrgyz Republic,KGZ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,56.0378512,56.2217136,56.405576,56.4651436,56.5247112,56.5842788,56.6438464,56.703414,57.9574198,59.2114256,60.4654314,61.7194372,62.973443,63.9626422,64.9518414,65.9410406,66.9302398,67.919439,68.1809368,68.4424346,68.7039324,..
Kyrgyz Republic,KGZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,74.1394856,74.3453398,74.551194,74.9763332,75.4014724,75.8266116,76.2517508,76.67689,77.5745942,78.4722984,79.3700026,80.2677068,81.165411,81.6911558,82.2169006,82.7426454,83.2683902,83.794135,83.9829036,84.1716722,84.3604408,..
Lao PDR,LAO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,51.9267976,52.7861468,53.645496,54.5480802,55.4506644,56.3532486,57.2558328,58.158417,58.9920566,59.8256962,60.6593358,61.4929754,62.326615,63.0122722,63.6979294,64.3835866,65.0692438,65.754901,66.2373152,66.7197294,67.2021436,..
Lao PDR,LAO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.6527914,60.5682162,61.483641,62.3790824,63.2745238,64.1699652,65.0654066,65.960848,66.7702398,67.5796316,68.3890234,69.1984152,70.007807,70.666187,71.324567,71.982947,72.641327,73.299707,73.835482,74.371257,74.907032,..
Latvia,LVA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,55.0572,56.0366,57.016,57.1846,57.3532,57.5218,57.6904,57.859,59.2569776,60.6549552,62.0529328,63.4509104,64.848888,65.3032216,65.7575552,66.2118888,66.6662224,67.120556,67.456779,67.793002,68.129225,..
Latvia,LVA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.2786,81.7888,82.299,82.4386,82.5782,82.7178,82.8574,82.997,83.4412688,83.8855376,84.3298064,84.7740752,85.218344,85.4331316,85.6479192,85.8627068,86.0774944,86.292282,86.4244358,86.5565896,86.6887434,..
Lebanon,LBN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,79.3532606,80.1605148,80.967769,81.6903112,82.4128534,83.1353956,83.8579378,84.58048,84.832721,85.084962,85.337203,85.589444,85.841685,85.8923374,85.9429898,85.9936422,86.0442946,86.094947,86.2425004,86.3900538,86.5376072,..
Lebanon,LBN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.1132624,85.8852982,86.657334,87.2143326,87.7713312,88.3283298,88.8853284,89.442327,89.6343574,89.8263878,90.0184182,90.2104486,90.402479,90.4345764,90.4666738,90.4987712,90.5308686,90.562966,90.6453828,90.7277996,90.8102164,..
Lesotho,LSO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,22.942329,20.536617,18.130905,17.4633636,16.7958222,16.1282808,15.4607394,14.793198,16.1814972,17.5697964,18.9580956,20.3463948,21.734694,23.7437446,25.7527952,27.7618458,29.7708964,31.779947,32.4390824,33.0982178,33.7573532,..
Lesotho,LSO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.830513,31.852095,27.873677,27.4175186,26.9613602,26.5052018,26.0490434,25.592885,27.5246874,29.4564898,31.3882922,33.3200946,35.251897,37.4757912,39.6996854,41.9235796,44.1474738,46.371368,47.0636038,47.7558396,48.4480754,..
Liberia,LBR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,44.8600192,44.6528876,44.445756,46.046451,47.647146,49.247841,50.848536,52.449231,53.2456272,54.0420234,54.8384196,55.6348158,56.431212,57.270559,58.109906,58.949253,59.7886,60.627947,61.0450918,61.4622366,61.8793814,..
Liberia,LBR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.7189986,49.4498068,49.180615,51.01817,52.855725,54.69328,56.530835,58.36839,59.1127596,59.8571292,60.6014988,61.3458684,62.090238,62.9546242,63.8190104,64.6833966,65.5477828,66.412169,66.888109,67.364049,67.839989,..
Libya,LBY,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,72.0254348,72.2432624,72.46109,72.652549,72.844008,73.035467,73.226926,73.418385,72.5657236,71.7130622,70.8604008,70.0077394,69.155078,69.7667888,70.3784996,70.9902104,71.6019212,72.213632,72.4701292,72.7266264,72.9831236,..
Libya,LBY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.7689778,80.0591764,80.349375,80.87118,81.392985,81.91479,82.436595,82.9584,82.8718356,82.7852712,82.6987068,82.6121424,82.525578,82.7514956,82.9774132,83.2033308,83.4292484,83.655166,83.8647144,84.0742628,84.2838112,..
Lithuania,LTU,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,58.2107218,58.7082734,59.205825,59.0972676,58.9887102,58.8801528,58.7715954,58.663038,59.5588324,60.4546268,61.3504212,62.2462156,63.14201,63.727896,64.313782,64.899668,65.485554,66.07144,66.4612474,66.8510548,67.2408622,..
Lithuania,LTU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.3741426,83.7713558,84.168569,84.1160064,84.0634438,84.0108812,83.9583186,83.905756,84.3292528,84.7527496,85.1762464,85.5997432,86.02324,86.3280286,86.6328172,86.9376058,87.2423944,87.547183,87.673966,87.800749,87.927532,..
Luxembourg,LUX,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,79.8736632,80.3812966,80.88893,81.3304336,81.7719372,82.2134408,82.6549444,83.096448,83.7274838,84.3585196,84.9895554,85.6205912,86.251627,86.541372,86.831117,87.120862,87.410607,87.700352,87.9608526,88.2213532,88.4818538,..
Luxembourg,LUX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.3767648,89.6162464,89.855728,89.9783448,90.1009616,90.2235784,90.3461952,90.468812,90.7620832,91.0553544,91.3486256,91.6418968,91.935168,92.0796036,92.2240392,92.3684748,92.5129104,92.657346,92.7759516,92.8945572,93.0131628,..
Madagascar,MDG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,52.8331426,53.7372998,54.641457,55.13616,55.630863,56.125566,56.620269,57.114972,57.8241016,58.5332312,59.2423608,59.9514904,60.66062,61.26247,61.86432,62.46617,63.06802,63.66987,64.2069244,64.7439788,65.2810332,..
Madagascar,MDG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,58.0313218,59.1379454,60.244569,60.9457964,61.6470238,62.3482512,63.0494786,63.750706,64.5019318,65.2531576,66.0043834,66.7556092,67.506835,68.1767386,68.8466422,69.5165458,70.1864494,70.856353,71.4444808,72.0326086,72.6207364,..
Malawi,MWI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,23.7870874,23.3380542,22.889021,24.6602614,26.4315018,28.2027422,29.9739826,31.745223,34.8093198,37.8734166,40.9375134,44.0016102,47.065707,48.320372,49.575037,50.829702,52.084367,53.339032,54.095794,54.852556,55.609318,..
Malawi,MWI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.5757264,33.8768602,33.177994,35.2079942,37.2379944,39.2679946,41.2979948,43.327995,46.7741338,50.2202726,53.6664114,57.1125502,60.558689,61.9436022,63.3285154,64.7134286,66.0983418,67.483255,68.2307908,68.9783266,69.7258624,..
Malaysia,MYS,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,72.905936,73.27357,73.641204,73.8440676,74.0469312,74.2497948,74.4526584,74.655522,74.8329472,75.0103724,75.1877976,75.3652228,75.542648,75.6975974,75.8525468,76.0074962,76.1624456,76.317395,76.5990742,76.8807534,77.1624326,..
Malaysia,MYS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.1698516,83.3465988,83.523346,83.7507418,83.9781376,84.2055334,84.4329292,84.660325,84.865799,85.071273,85.276747,85.482221,85.687695,85.8734352,86.0591754,86.2449156,86.4306558,86.616396,86.7895766,86.9627572,87.1359378,..
Maldives,MDV,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,73.7355708,74.9610094,76.186448,77.1176908,78.0489336,78.9801764,79.9114192,80.842662,81.5465862,82.2505104,82.9544346,83.6583588,84.362283,84.8918392,85.4213954,85.9509516,86.4805078,87.010064,87.348076,87.686088,88.0241,..
Maldives,MDV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.7398514,78.0392832,79.338715,80.4512218,81.5637286,82.6762354,83.7887422,84.901249,85.7159188,86.5305886,87.3452584,88.1599282,88.974598,89.5404954,90.1063928,90.6722902,91.2381876,91.804085,92.009968,92.215851,92.421734,..
Mali,MLI,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,42.7835464,43.6362912,44.489036,45.5221338,46.5552316,47.5883294,48.6214272,49.654525,50.1638962,50.6732674,51.1826386,51.6920098,52.201381,52.9292298,53.6570786,54.3849274,55.1127762,55.840625,56.3718626,56.9031002,57.4343378,..
Mali,MLI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,45.307374,46.112585,46.917796,47.9963618,49.0749276,50.1534934,51.2320592,52.310625,52.8590044,53.4073838,53.9557632,54.5041426,55.052522,55.8164502,56.5803784,57.3443066,58.1082348,58.872163,59.4792082,60.0862534,60.6932986,..
Malta,MLT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,86.0887034,86.4690112,86.849319,87.007114,87.164909,87.322704,87.480499,87.638294,87.8058772,87.9734604,88.1410436,88.3086268,88.47621,88.7034794,88.9307488,89.1580182,89.3852876,89.612557,89.8119454,90.0113338,90.2107222,..
Malta,MLT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.5232576,91.6103058,91.697354,91.820943,91.944532,92.068121,92.19171,92.315299,92.4604204,92.6055418,92.7506632,92.8957846,93.040906,93.1333746,93.2258432,93.3183118,93.4107804,93.503249,93.5954238,93.6875986,93.7797734,..
Mauritania,MRT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,56.3008524,56.4071202,56.513388,56.84017,57.166952,57.493734,57.820516,58.147298,58.553784,58.96027,59.366756,59.773242,60.179728,60.613159,61.04659,61.480021,61.913452,62.346883,62.6202132,62.8935434,63.1668736,..
Mauritania,MRT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.7757326,63.9671438,64.158555,64.4174796,64.6764042,64.9353288,65.1942534,65.453178,65.8101248,66.1670716,66.5240184,66.8809652,67.237912,67.5881534,67.9383948,68.2886362,68.6388776,68.989119,69.3147068,69.6402946,69.9658824,..
Mauritius,MUS,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.1113944,65.8304032,66.549412,66.9113296,67.2732472,67.6351648,67.9970824,68.359,68.8336,69.3082,69.7828,70.2574,70.732,70.9856266,71.2392532,71.4928798,71.7465064,72.000133,72.279447,72.558761,72.838075,..
Mauritius,MUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.9752714,80.0176142,80.059957,80.5289656,80.9979742,81.4669828,81.9359914,82.405,82.7592,83.1134,83.4676,83.8218,84.176,84.2710022,84.3660044,84.4610066,84.5560088,84.651011,84.8167168,84.9824226,85.1481284,..
Mexico,MEX,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,72.6948174,73.3003012,73.905785,73.8641268,73.8224686,73.7808104,73.7391522,73.697494,73.5510572,73.4046204,73.2581836,73.1117468,72.96531,73.003421,73.041532,73.079643,73.117754,73.155865,73.315318,73.474771,73.634224,..
Mexico,MEX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.7949488,83.2693994,83.74385,83.8196832,83.8955164,83.9713496,84.0471828,84.123016,84.1074316,84.0918472,84.0762628,84.0606784,84.045094,84.0406382,84.0361824,84.0317266,84.0272708,84.022815,84.1076902,84.1925654,84.2774406,..
"Micronesia, Fed. Sts.",FSM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,64.1852632,64.3996266,64.61399,64.9570652,65.3001404,65.6432156,65.9862908,66.329366,66.525061,66.720756,66.916451,67.112146,67.307841,67.5541662,67.8004914,68.0468166,68.2931418,68.539467,68.7100834,68.8806998,69.0513162,..
"Micronesia, Fed. Sts.",FSM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.9961488,70.2234424,70.450736,70.8051888,71.1596416,71.5140944,71.8685472,72.223,72.5228192,72.8226384,73.1224576,73.4222768,73.722096,73.9742354,74.2263748,74.4785142,74.7306536,74.982793,75.2226232,75.4624534,75.7022836,..
Moldova,MDA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,54.4761796,54.7235178,54.970856,55.2248828,55.4789096,55.7329364,55.9869632,56.24099,57.3907112,58.5404324,59.6901536,60.8398748,61.989596,62.2798562,62.5701164,62.8603766,63.1506368,63.440897,63.6948142,63.9487314,64.2026486,..
Moldova,MDA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,73.7990392,74.0712736,74.343508,74.5126414,74.6817748,74.8509082,75.0200416,75.189175,76.5112514,77.8333278,79.1554042,80.4774806,81.799557,82.013977,82.228397,82.442817,82.657237,82.871657,83.047529,83.223401,83.399273,..
Monaco,MCO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..
Monaco,MCO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..,..
Mongolia,MNG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,51.4541416,51.4919268,51.529712,52.151952,52.774192,53.396432,54.018672,54.640912,55.1642472,55.6875824,56.2109176,56.7342528,57.257588,57.5954768,57.9333656,58.2712544,58.6091432,58.947032,59.3173236,59.6876152,60.0579068,..
Mongolia,MNG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.3374628,67.4717044,68.605946,69.6732346,70.7405232,71.8078118,72.8751004,73.942389,74.5908248,75.2392606,75.8876964,76.5361322,77.184568,77.5586334,77.9326988,78.3067642,78.6808296,79.054895,79.3633214,79.6717478,79.9801742,..
Montenegro,MNE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,72.120003,72.120003,72.120003,72.5864576,73.0529122,73.5193668,73.9858214,74.452276,75.0989834,75.7456908,76.3923982,77.0391056,77.685813,78.0514982,78.4171834,78.7828686,79.1485538,79.514239,79.7901314,80.0660238,80.3419162,..
Montenegro,MNE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.129202,84.129202,84.129202,84.243318,84.357434,84.47155,84.585666,84.699782,85.350656,86.00153,86.652404,87.303278,87.954152,88.130242,88.306332,88.482422,88.658512,88.834602,88.9989944,89.1633868,89.3277792,..
Morocco,MAR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,70.1466066,71.1549698,72.163333,73.8838724,75.6044118,77.3249512,79.0454906,80.76603,81.4342416,82.1024532,82.7706648,83.4388764,84.107088,84.474735,84.842382,85.210029,85.577676,85.945323,86.225374,86.505425,86.785476,..
Morocco,MAR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.5346572,77.2954846,78.056312,79.3214204,80.5865288,81.8516372,83.1167456,84.381854,84.8760596,85.3702652,85.8644708,86.3586764,86.852882,87.1446022,87.4363224,87.7280426,88.0197628,88.311483,88.5728042,88.8341254,89.0954466,..
Mozambique,MOZ,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,34.3212396,34.2028948,34.08455,33.8037208,33.5228916,33.2420624,32.9612332,32.680404,33.2347668,33.7891296,34.3434924,34.8978552,35.452218,37.646532,39.840846,42.03516,44.229474,46.423788,47.1340844,47.8443808,48.5546772,..
Mozambique,MOZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.6699022,43.5911056,43.512309,43.4028232,43.2933374,43.1838516,43.0743658,42.96488,43.9926248,45.0203696,46.0481144,47.0758592,48.103604,50.5922268,53.0808496,55.5694724,58.0580952,60.546718,61.2609172,61.9751164,62.6893156,..
Myanmar,MMR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,49.9015458,50.4368874,50.972229,51.346914,51.721599,52.096284,52.470969,52.845654,53.6396712,54.4336884,55.2277056,56.0217228,56.81574,57.697881,58.580022,59.462163,60.344304,61.226445,61.555435,61.884425,62.213415,..
Myanmar,MMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,62.9840778,63.4536624,63.923247,64.6091082,65.2949694,65.9808306,66.6666918,67.352553,68.1077554,68.8629578,69.6181602,70.3733626,71.128565,71.766488,72.404411,73.042334,73.680257,74.31818,74.659279,75.000378,75.341477,..
Namibia,NAM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,31.2841006,29.5279808,27.771861,28.4227846,29.0737082,29.7246318,30.3755554,31.026479,33.7859692,36.5454594,39.3049496,42.0644398,44.82393,46.1476098,47.4712896,48.7949694,50.1186492,51.442329,52.0940548,52.7457806,53.3975064,..
Namibia,NAM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.5304654,39.1414762,36.752487,37.1367594,37.5210318,37.9053042,38.2895766,38.673849,42.3983218,46.1227946,49.8472674,53.5717402,57.296213,58.73518,60.174147,61.613114,63.052081,64.491048,65.1646536,65.8382592,66.5118648,..
Nepal,NPL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,58.5632114,59.6076072,60.652003,61.4905372,62.3290714,63.1676056,64.0061398,64.844674,65.5907024,66.3367308,67.0827592,67.8287876,68.574816,69.1472102,69.7196044,70.2919986,70.8643928,71.436787,71.9251878,72.4135886,72.9019894,..
Nepal,NPL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.98598,65.13615,66.28632,67.2091908,68.1320616,69.0549324,69.9778032,70.900674,71.6493542,72.3980344,73.1467146,73.8953948,74.644075,75.2349726,75.8258702,76.4167678,77.0076654,77.598563,78.117778,78.636993,79.156208,..
Netherlands,NLD,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,83.8709054,84.2327422,84.594579,85.0441408,85.4937026,85.9432644,86.3928262,86.842388,87.2094336,87.5764792,87.9435248,88.3105704,88.677616,88.7264534,88.7752908,88.8241282,88.8729656,88.921803,89.1248102,89.3278174,89.5308246,..
Netherlands,NLD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.4050698,89.4892624,89.573455,89.7816432,89.9898314,90.1980196,90.4062078,90.614396,90.7895134,90.9646308,91.1397482,91.3148656,91.489983,91.768229,92.046475,92.324721,92.602967,92.881213,92.9845996,93.0879862,93.1913728,..
New Zealand,NZL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,83.3172976,83.9373488,84.5574,84.8732092,85.1890184,85.5048276,85.8206368,86.136446,86.4203376,86.7042292,86.9881208,87.2720124,87.555904,87.749151,87.942398,88.135645,88.328892,88.522139,88.7260626,88.9299862,89.1339098,..
New Zealand,NZL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,88.8447852,89.1589506,89.473116,89.7125404,89.9519648,90.1913892,90.4308136,90.670238,90.832053,90.993868,91.155683,91.317498,91.479313,91.6161304,91.7529478,91.8897652,92.0265826,92.1634,92.274524,92.385648,92.496772,..
Nicaragua,NIC,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.2581098,65.8479234,66.437737,66.7593142,67.0808914,67.4024686,67.7240458,68.045623,68.4028004,68.7599778,69.1171552,69.4743326,69.83151,70.109512,70.387514,70.665516,70.943518,71.22152,71.5767024,71.9318848,72.2870672,..
Nicaragua,NIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.7308922,76.4390476,77.147203,77.5390938,77.9309846,78.3228754,78.7147662,79.106657,79.5339646,79.9612722,80.3885798,80.8158874,81.243195,81.6176044,81.9920138,82.3664232,82.7408326,83.115242,83.361718,83.608194,83.85467,..
Niger,NER,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,45.6707692,46.3437006,47.016632,47.8184664,48.6203008,49.4221352,50.2239696,51.025804,51.8337162,52.6416284,53.4495406,54.2574528,55.065365,55.7990564,56.5327478,57.2664392,58.0001306,58.733822,59.2802788,59.8267356,60.3731924,..
Niger,NER,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,48.8277062,49.5214756,50.215245,51.1543844,52.0935238,53.0326632,53.9718026,54.910942,55.9377134,56.9644848,57.9912562,59.0180276,60.044799,60.8204636,61.5961282,62.3717928,63.1474574,63.923122,64.532898,65.142674,65.75245,..
Nigeria,NGA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,35.9027272,35.9748186,36.04691,36.8109584,37.5750068,38.3390552,39.1031036,39.867152,40.4472328,41.0273136,41.6073944,42.1874752,42.767556,43.3743498,43.9811436,44.5879374,45.1947312,45.801525,46.2521844,46.7028438,47.1535032,..
Nigeria,NGA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.0255444,39.9849622,39.94438,40.6643456,41.3843112,42.1042768,42.8242424,43.544208,44.1948712,44.8455344,45.4961976,46.1468608,46.797524,47.502328,48.207132,48.911936,49.61674,50.321544,50.8325194,51.3434948,51.8544702,..
North Macedonia,MKD,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,73.9829658,74.1905804,74.398195,74.774771,75.151347,75.527923,75.904499,76.281075,76.6855834,77.0900918,77.4946002,77.8991086,78.303617,78.4812934,78.6589698,78.8366462,79.0143226,79.191999,79.4173682,79.6427374,79.8681066,..
North Macedonia,MKD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.0520776,85.4901948,85.928312,85.983949,86.039586,86.095223,86.15086,86.206497,86.483181,86.759865,87.036549,87.313233,87.589917,87.6983858,87.8068546,87.9153234,88.0237922,88.132261,88.2992964,88.4663318,88.6333672,..
Norway,NOR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.1404614,84.5332772,84.926093,85.289138,85.652183,86.015228,86.378273,86.741318,87.0406578,87.3399976,87.6393374,87.9386772,88.238017,88.3693378,88.5006586,88.6319794,88.7633002,88.894621,89.1034812,89.3123414,89.5212016,..
Norway,NOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,90.3519906,90.4739968,90.596003,90.7817846,90.9675662,91.1533478,91.3391294,91.524911,91.707014,91.889117,92.07122,92.253323,92.435426,92.5226204,92.6098148,92.6970092,92.7842036,92.871398,92.9741656,93.0769332,93.1797008,..
Oman,OMN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,74.4508934,75.1637742,75.876655,76.4829172,77.0891794,77.6954416,78.3017038,78.907966,79.3196998,79.7314336,80.1431674,80.5549012,80.966635,81.3716072,81.7765794,82.1815516,82.5865238,82.991496,83.296373,83.60125,83.906127,..
Oman,OMN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.5190544,82.1378632,82.756672,83.2578178,83.7589636,84.2601094,84.7612552,85.262401,85.5417218,85.8210426,86.1003634,86.3796842,86.659005,86.9484956,87.2379862,87.5274768,87.8169674,88.106458,88.288315,88.470172,88.652029,..
Pakistan,PAK,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,62.7468412,63.0639136,63.380986,63.6476766,63.9143672,64.1810578,64.4477484,64.714439,65.1842,65.653961,66.123722,66.593483,67.063244,67.3361106,67.6089772,67.8818438,68.1547104,68.427577,68.617114,68.806651,68.996188,..
Pakistan,PAK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.4701528,66.7528894,67.035626,67.3411466,67.6466672,67.9521878,68.2577084,68.563229,69.147276,69.731323,70.31537,70.899417,71.483464,71.7196334,71.9558028,72.1919722,72.4281416,72.664311,72.9209498,73.1775886,73.4342274,..
Panama,PAN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.5540966,75.6718878,75.789679,75.8156236,75.8415682,75.8675128,75.8934574,75.919402,76.1368836,76.3543652,76.5718468,76.7893284,77.00681,77.202289,77.397768,77.593247,77.788726,77.984205,78.2438336,78.5034622,78.7630908,..
Panama,PAN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.4782798,84.6145594,84.750839,84.8792572,85.0076754,85.1360936,85.2645118,85.39293,85.585123,85.777316,85.969509,86.161702,86.353895,86.5446952,86.7354954,86.9262956,87.1170958,87.307896,87.4465018,87.5851076,87.7237134,..
Papua New Guinea,PNG,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,51.6704836,52.2296668,52.78885,53.3669848,53.9451196,54.5232544,55.1013892,55.679524,56.1021054,56.5246868,56.9472682,57.3698496,57.792431,58.2498512,58.7072714,59.1646916,59.6221118,60.079532,60.4152464,60.7509608,61.0866752,..
Papua New Guinea,PNG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,60.3510948,60.7302254,61.109356,61.687337,62.265318,62.843299,63.42128,63.999261,64.4308172,64.8623734,65.2939296,65.7254858,66.157042,66.5505558,66.9440696,67.3375834,67.7310972,68.124611,68.5306112,68.9366114,69.3426116,..
Paraguay,PRY,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,69.645521,70.051534,70.457547,70.7403048,71.0230626,71.3058204,71.5885782,71.871336,72.2272112,72.5830864,72.9389616,73.2948368,73.650712,73.8988394,74.1469668,74.3950942,74.6432216,74.891349,75.0227832,75.1542174,75.2856516,..
Paraguay,PRY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.4079784,76.6131692,76.81836,77.1103036,77.4022472,77.6941908,77.9861344,78.278078,78.536869,78.79566,79.054451,79.313242,79.572033,79.8655912,80.1591494,80.4527076,80.7462658,81.039824,81.1960598,81.3522956,81.5085314,..
Peru,PER,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,71.2142602,71.7381886,72.262117,72.6953584,73.1285998,73.5618412,73.9950826,74.428324,74.8174102,75.2064964,75.5955826,75.9846688,76.373755,76.705466,77.037177,77.368888,77.700599,78.03231,78.3653226,78.6983352,79.0313478,..
Peru,PER,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.517448,80.043245,80.569042,80.990277,81.411512,81.832747,82.253982,82.675217,83.0428022,83.4103874,83.7779726,84.1455578,84.513143,84.8349148,85.1566866,85.4784584,85.8002302,86.122002,86.3436358,86.5652696,86.7869034,..
Philippines,PHL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,63.1880772,63.0870186,62.98596,63.0264182,63.0668764,63.1073346,63.1477928,63.188251,63.2880734,63.3878958,63.4877182,63.5875406,63.687363,63.9180282,64.1486934,64.3793586,64.6100238,64.840689,65.043157,65.245625,65.448093,..
Philippines,PHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.2455102,78.1841116,78.122713,78.1584284,78.1941438,78.2298592,78.2655746,78.30129,78.4085236,78.5157572,78.6229908,78.7302244,78.837458,78.945291,79.053124,79.160957,79.26879,79.376623,79.5508162,79.7250094,79.8992026,..
Poland,POL,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,67.9543672,68.7501286,69.54589,69.7784974,70.0111048,70.2437122,70.4763196,70.708927,71.3893832,72.0698394,72.7502956,73.4307518,74.111208,74.5796418,75.0480756,75.5165094,75.9849432,76.453377,76.793768,77.134159,77.47455,..
Poland,POL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,86.2591424,86.6088932,86.958644,87.074698,87.190752,87.306806,87.42286,87.538914,87.8217216,88.1045292,88.3873368,88.6701444,88.952952,89.1555112,89.3580704,89.5606296,89.7631888,89.965748,90.0933466,90.2209452,90.3485438,..
Portugal,PRT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,77.8914508,78.4420634,78.992676,79.4716608,79.9506456,80.4296304,80.9086152,81.3876,81.7689472,82.1502944,82.5316416,82.9129888,83.294336,83.630596,83.966856,84.303116,84.639376,84.975636,85.2746742,85.5737124,85.8727506,..
Portugal,PRT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.7517282,90.0313026,90.310877,90.6011334,90.8913898,91.1816462,91.4719026,91.762159,91.9555378,92.1489166,92.3422954,92.5356742,92.729053,92.8931198,93.0571866,93.2212534,93.3853202,93.549387,93.656401,93.763415,93.870429,..
Qatar,QAT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,86.1195784,86.5103792,86.90118,87.3224222,87.7436644,88.1649066,88.5861488,89.007391,89.4058932,89.8043954,90.2028976,90.6013998,90.999902,91.347153,91.694404,92.041655,92.388906,92.736157,92.8572002,92.9782434,93.0992866,..
Qatar,QAT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.7311744,86.1139202,86.496666,86.911677,87.326688,87.741699,88.15671,88.571721,88.9567584,89.3417958,89.7268332,90.1118706,90.496908,90.8163916,91.1358752,91.4553588,91.7748424,92.094326,92.1931572,92.2919884,92.3908196,..
Romania,ROU,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,63.2490464,63.9620022,64.674958,65.2760546,65.8771512,66.4782478,67.0793444,67.680441,68.3878658,69.0952906,69.8027154,70.5101402,71.217565,71.4999102,71.7822554,72.0646006,72.3469458,72.629291,72.9171654,73.2050398,73.4929142,..
Romania,ROU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.5821144,82.0127762,82.443438,82.8937292,83.3440204,83.7943116,84.2446028,84.694894,85.0769122,85.4589304,85.8409486,86.2229668,86.604985,86.8010784,86.9971718,87.1932652,87.3893586,87.585452,87.7308258,87.8761996,88.0215734,..
Russian Federation,RUS,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,43.1501686,42.3622978,41.574427,42.686702,43.798977,44.911252,46.023527,47.135802,48.8462998,50.5567976,52.2672954,53.9777932,55.688291,56.635997,57.583703,58.531409,59.479115,60.426821,60.7597112,61.0926014,61.4254916,..
Russian Federation,RUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.6180656,75.3331448,75.048224,75.6005992,76.1529744,76.7053496,77.2577248,77.8101,78.5545124,79.2989248,80.0433372,80.7877496,81.532162,81.9708854,82.4096088,82.8483322,83.2870556,83.725779,83.8964286,84.0670782,84.2377278,..
Rwanda,RWA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,35.965843,37.254724,38.543605,41.5654456,44.5872862,47.6091268,50.6309674,53.652808,55.378036,57.103264,58.828492,60.55372,62.278948,63.105658,63.932368,64.759078,65.585788,66.412498,66.9005076,67.3885172,67.8765268,..
Rwanda,RWA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.6681364,41.0004832,42.33283,45.8353294,49.3378288,52.8403282,56.3428276,59.845327,61.8784916,63.9116562,65.9448208,67.9779854,70.01115,70.9233012,71.8354524,72.7476036,73.6597548,74.571906,75.09147,75.611034,76.130598,..
Samoa,WSM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.600455,66.425317,67.250179,67.9320072,68.6138354,69.2956636,69.9774918,70.65932,71.3528338,72.0463476,72.7398614,73.4333752,74.126889,74.5717454,75.0166018,75.4614582,75.9063146,76.351171,76.5466784,76.7421858,76.9376932,..
Samoa,WSM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.7716632,78.3652716,78.95888,79.4353446,79.9118092,80.3882738,80.8647384,81.341203,81.8275908,82.3139786,82.8003664,83.2867542,83.773142,84.0397816,84.3064212,84.5730608,84.8397004,85.10634,85.3114276,85.5165152,85.7216028,..
Sao Tome and Principe,STP,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,55.7285974,56.6750122,57.621427,58.574834,59.528241,60.481648,61.435055,62.388462,63.1803114,63.9721608,64.7640102,65.5558596,66.347709,66.8832928,67.4188766,67.9544604,68.4900442,69.025628,69.2787794,69.5319308,69.7850822,..
Sao Tome and Principe,STP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.6537044,65.6951072,66.73651,67.7653444,68.7941788,69.8230132,70.8518476,71.880682,72.7001688,73.5196556,74.3391424,75.1586292,75.978116,76.534021,77.089926,77.645831,78.201736,78.757641,79.0430648,79.3284886,79.6139124,..
Saudi Arabia,SAU,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,76.4543798,76.9869784,77.519577,77.7482332,77.9768894,78.2055456,78.4342018,78.662858,78.9956592,79.3284604,79.6612616,79.9940628,80.326864,80.5560338,80.7852036,81.0143734,81.2435432,81.472713,81.708366,81.944019,82.179672,..
Saudi Arabia,SAU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.7599892,82.8774926,82.994996,83.0262034,83.0574108,83.0886182,83.1198256,83.151033,83.4333356,83.7156382,83.9979408,84.2802434,84.562546,84.6790024,84.7954588,84.9119152,85.0283716,85.144828,85.378604,85.61238,85.846156,..
Senegal,SEN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,53.3528118,53.6221714,53.891531,54.944511,55.997491,57.050471,58.103451,59.156431,59.9636562,60.7708814,61.5781066,62.3853318,63.192557,63.6575158,64.1224746,64.5874334,65.0523922,65.517351,65.9506318,66.3839126,66.8171934,..
Senegal,SEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,60.8087312,61.2139076,61.619084,62.5178122,63.4165404,64.3152686,65.2139968,66.112725,67.2724662,68.4322074,69.5919486,70.7516898,71.911431,72.5471754,73.1829198,73.8186642,74.4544086,75.090153,75.548281,76.006409,76.464537,..
Serbia,SRB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,69.3917336,69.5286058,69.665478,70.0928994,70.5203208,70.9477422,71.3751636,71.802585,72.3688812,72.9351774,73.5014736,74.0677698,74.634066,75.0600904,75.4861148,75.9121392,76.3381636,76.764188,77.0296502,77.2951124,77.5605746,..
Serbia,SRB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.929674,83.065499,83.201324,83.5508678,83.9004116,84.2499554,84.5994992,84.949043,85.2636012,85.5781594,85.8927176,86.2072758,86.521834,86.7318732,86.9419124,87.1519516,87.3619908,87.57203,87.740377,87.908724,88.077071,..
Sierra Leone,SLE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,25.644927,26.750734,27.856541,29.2124734,30.5684058,31.9243382,33.2802706,34.636203,35.6566162,36.6770294,37.6974426,38.7178558,39.738269,40.394634,41.050999,41.707364,42.363729,43.020094,43.518578,44.017062,44.515546,..
Sierra Leone,SLE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.0401666,31.2916208,32.543075,33.9173126,35.2915502,36.6657878,38.0400254,39.414263,40.578007,41.741751,42.905495,44.069239,45.232983,45.8849908,46.5369986,47.1890064,47.8410142,48.493022,49.0448354,49.5966488,50.1484622,..
Singapore,SGP,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,82.7757138,83.5330954,84.290477,84.7815558,85.2726346,85.7637134,86.2547922,86.745871,87.0990968,87.4523226,87.8055484,88.1587742,88.512,88.8024348,89.0928696,89.3833044,89.6737392,89.964174,90.120636,90.277098,90.43356,..
Singapore,SGP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,89.968353,90.53995,91.111547,91.350577,91.589607,91.828637,92.067667,92.306697,92.4941576,92.6816182,92.8690788,93.0565394,93.244,93.4199778,93.5959556,93.7719334,93.9479112,94.123889,94.2088426,94.2937962,94.3787498,..
Slovak Republic,SVK,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,67.6162992,68.0958206,68.575342,69.0242694,69.4731968,69.9221242,70.3710516,70.819979,71.5100844,72.2001898,72.8902952,73.5804006,74.270506,74.7528344,75.2351628,75.7174912,76.1998196,76.682148,76.9781656,77.2741832,77.5702008,..
Slovak Republic,SVK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,86.1910118,86.4692614,86.747511,86.9181592,87.0888074,87.2594556,87.4301038,87.600752,87.8447894,88.0888268,88.3328642,88.5769016,88.820939,89.0025948,89.1842506,89.3659064,89.5475622,89.729218,89.8590514,89.9888848,90.1187182,..
Slovenia,SVN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,74.5829714,75.1893132,75.795655,76.5401196,77.2845842,78.0290488,78.7735134,79.517978,80.2196154,80.9212528,81.6228902,82.3245276,83.026165,83.4618314,83.8974978,84.3331642,84.7688306,85.204497,85.5206552,85.8368134,86.1529716,..
Slovenia,SVN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,88.6140956,88.8997568,89.185418,89.5551538,89.9248896,90.2946254,90.6643612,91.034097,91.2304674,91.4268378,91.6232082,91.8195786,92.015949,92.1303918,92.2448346,92.3592774,92.4737202,92.588163,92.7171056,92.8460482,92.9749908,..
Solomon Islands,SLB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,63.3917608,64.1505894,64.909418,65.5111992,66.1129804,66.7147616,67.3165428,67.918324,68.5896402,69.2609564,69.9322726,70.6035888,71.274905,71.7893232,72.3037414,72.8181596,73.3325778,73.846996,74.0124356,74.1778752,74.3433148,..
Solomon Islands,SLB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.2026464,70.0454902,70.888334,71.6111128,72.3338916,73.0566704,73.7794492,74.502228,75.1478168,75.7934056,76.4389944,77.0845832,77.730172,78.210325,78.690478,79.170631,79.650784,80.130937,80.3348812,80.5388254,80.7427696,..
Somalia,SOM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,41.4415054,41.8878242,42.334143,42.8138874,43.2936318,43.7733762,44.2531206,44.732865,45.165593,45.598321,46.031049,46.463777,46.896505,47.4979648,48.0994246,48.7008844,49.3023442,49.903804,50.3015434,50.6992828,51.0970222,..
Somalia,SOM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.6388148,48.0881444,48.537474,49.0267862,49.5160984,50.0054106,50.4947228,50.984035,51.46091,51.937785,52.41466,52.891535,53.36841,53.9812626,54.5941152,55.2069678,55.8198204,56.432673,56.869245,57.305817,57.742389,..
South Africa,ZAF,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,37.9758748,36.0384164,34.100958,34.114456,34.127954,34.141452,34.15495,34.168448,36.1901972,38.2119464,40.2336956,42.2554448,44.277194,45.3991108,46.5210276,47.6429444,48.7648612,49.886778,50.3540324,50.8212868,51.2885412,..
South Africa,ZAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,51.931366,49.178082,46.424798,46.41821,46.411622,46.405034,46.398446,46.391858,49.0635706,51.7352832,54.4069958,57.0787084,59.750421,60.9975418,62.2446626,63.4917834,64.7389042,65.986025,66.4580592,66.9300934,67.4021276,..
Spain,ESP,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,82.026929,82.39716,82.767391,83.1795486,83.5917062,84.0038638,84.4160214,84.828179,85.2395706,85.6509622,86.0623538,86.4737454,86.885137,87.1194988,87.3538606,87.5882224,87.8225842,88.056946,88.209913,88.36288,88.515847,..
Spain,ESP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,92.3278248,92.4833744,92.638924,92.769315,92.899706,93.030097,93.160488,93.290879,93.3821442,93.4734094,93.5646746,93.6559398,93.747205,93.863064,93.978923,94.094782,94.210641,94.3265,94.4255138,94.5245276,94.6235414,..
Sri Lanka,LKA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,67.6015036,69.5392048,71.476906,71.9206196,72.3643332,72.8080468,73.2517604,73.695474,74.105274,74.515074,74.924874,75.334674,75.744474,76.1220994,76.4997248,76.8773502,77.2549756,77.632601,77.928599,78.224597,78.520595,..
Sri Lanka,LKA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.0174668,85.4078704,86.798274,87.0692546,87.3402352,87.6112158,87.8821964,88.153177,88.3953022,88.6374274,88.8795526,89.1216778,89.363803,89.5797596,89.7957162,90.0116728,90.2276294,90.443586,90.5837024,90.7238188,90.8639352,..
St. Lucia,LCA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,71.5742834,71.8921712,72.210059,72.4535162,72.6969734,72.9404306,73.1838878,73.427345,73.592168,73.756991,73.921814,74.086637,74.25146,74.3105328,74.3696056,74.4286784,74.4877512,74.546824,74.9020604,75.2572968,75.6125332,..
St. Lucia,LCA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.5428602,82.0159536,82.489047,82.6937024,82.8983578,83.1030132,83.3076686,83.512324,83.5261964,83.5400688,83.5539412,83.5678136,83.581686,83.6883008,83.7949156,83.9015304,84.0081452,84.11476,84.2975366,84.4803132,84.6630898,..
St. Vincent and the Grenadines,VCT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,68.4880594,68.4644262,68.440793,68.6725928,68.9043926,69.1361924,69.3679922,69.599792,69.5194294,69.4390668,69.3587042,69.2783416,69.197979,69.2624678,69.3269566,69.3914454,69.4559342,69.520423,69.7063152,69.8922074,70.0780996,..
St. Vincent and the Grenadines,VCT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.6569066,78.0170458,78.377185,78.6924822,79.0077794,79.3230766,79.6383738,79.953671,79.9799246,80.0061782,80.0324318,80.0586854,80.084939,80.1636882,80.2424374,80.3211866,80.3999358,80.478685,80.6831458,80.8876066,81.0920674,..
Sudan,SDN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,51.8801798,52.3454174,52.810655,53.542191,54.273727,55.005263,55.736799,56.468335,57.215013,57.961691,58.708369,59.455047,60.201725,60.5336258,60.8655266,61.1974274,61.5293282,61.861229,62.1857546,62.5102802,62.8348058,..
Sudan,SDN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.9061102,60.4962836,61.086457,61.6782746,62.2700922,62.8619098,63.4537274,64.045545,64.6738514,65.3021578,65.9304642,66.5587706,67.187077,67.589124,67.991171,68.393218,68.795265,69.197312,69.5758718,69.9544316,70.3329914,..
Suriname,SUR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,61.1141848,61.0948534,61.075522,61.790661,62.5058,63.220939,63.936078,64.651217,65.047939,65.444661,65.841383,66.238105,66.634827,66.7969616,66.9590962,67.1212308,67.2833654,67.4455,67.6529264,67.8603528,68.0677792,..
Suriname,SUR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.1153692,75.1758856,75.236402,75.776586,76.31677,76.856954,77.397138,77.937322,78.2758614,78.6144008,78.9529402,79.2914796,79.630019,79.7992702,79.9685214,80.1377726,80.3070238,80.476275,80.677138,80.878001,81.078864,..
Sweden,SWE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,85.8978568,86.2123804,86.526904,86.774255,87.021606,87.268957,87.516308,87.763659,88.0076266,88.2515942,88.4955618,88.7395294,88.983497,89.134352,89.285207,89.436062,89.586917,89.737772,89.9415954,90.1454188,90.3492422,..
Sweden,SWE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.0825162,91.2021096,91.321703,91.4656414,91.6095798,91.7535182,91.8974566,92.041395,92.1963108,92.3512266,92.5061424,92.6610582,92.815974,92.9171054,93.0182368,93.1193682,93.2204996,93.321631,93.4221178,93.5226046,93.6230914,..
Switzerland,CHE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,84.5871294,85.0237362,85.460343,85.8401872,86.2200314,86.5998756,86.9797198,87.359564,87.688786,88.018008,88.34723,88.676452,89.005674,89.2521066,89.4985392,89.7449718,89.9914044,90.237837,90.4089182,90.5799994,90.7510806,..
Switzerland,CHE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,91.4932164,91.6447182,91.79622,91.9576614,92.1191028,92.2805442,92.4419856,92.603427,92.7610566,92.9186862,93.0763158,93.2339454,93.391575,93.5048256,93.6180762,93.7313268,93.8445774,93.957828,94.0561438,94.1544596,94.2527754,..
Syrian Arab Republic,SYR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.1988336,75.4276768,75.65652,75.865749,76.074978,76.284207,76.493436,76.702665,73.8889674,71.0752698,68.2615722,65.4478746,62.634177,63.1934018,63.7526266,64.3118514,64.8710762,65.430301,68.1836702,70.9370394,73.6904086,..
Syrian Arab Republic,SYR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.2278506,84.5247828,84.821715,85.112387,85.403059,85.693731,85.984403,86.275075,85.9930864,85.7110978,85.4291092,85.1471206,84.865132,85.2502262,85.6353204,86.0204146,86.4055088,86.790603,87.3851604,87.9797178,88.5742752,..
Tajikistan,TJK,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,58.3351392,59.4486716,60.562204,61.6487888,62.7353736,63.8219584,64.9085432,65.995128,66.5168262,67.0385244,67.5602226,68.0819208,68.603619,69.1706866,69.7377542,70.3048218,70.8718894,71.438957,71.7402854,72.0416138,72.3429422,..
Tajikistan,TJK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.3869408,67.7067944,69.026648,70.2467472,71.4668464,72.6869456,73.9070448,75.127144,75.8636496,76.6001552,77.3366608,78.0731664,78.809672,79.222588,79.635504,80.04842,80.461336,80.874252,81.1966518,81.5190516,81.8414514,..
Tanzania,TZA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,35.4707918,36.1326644,36.794537,38.186915,39.579293,40.971671,42.364049,43.756427,45.2967278,46.8370286,48.3773294,49.9176302,51.457931,53.4248556,55.3917802,57.3587048,59.3256294,61.292554,61.7774828,62.2624116,62.7473404,..
Tanzania,TZA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.9761616,44.4683538,44.960546,46.0493402,47.1381344,48.2269286,49.3157228,50.404517,52.7129546,55.0213922,57.3298298,59.6382674,61.946705,63.337471,64.728237,66.119003,67.509769,68.900535,69.4327122,69.9648894,70.4970666,..
Thailand,THA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.5520146,65.8887548,66.225495,66.901605,67.577715,68.253825,68.929935,69.606045,70.075544,70.545043,71.014542,71.484041,71.95354,72.3767276,72.7999152,73.2231028,73.6462904,74.069478,74.3950138,74.7205496,75.0460854,..
Thailand,THA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.398254,79.546412,79.69457,80.2390698,80.7835696,81.3280694,81.8725692,82.417069,83.0000254,83.5829818,84.1659382,84.7488946,85.331851,85.7638796,86.1959082,86.6279368,87.0599654,87.491994,87.6490086,87.8060232,87.9630378,..
Timor-Leste,TLS,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,53.1519362,54.4122076,55.672479,57.8337138,59.9949486,62.1561834,64.3174182,66.478653,66.7662616,67.0538702,67.3414788,67.6290874,67.916696,68.2977184,68.6787408,69.0597632,69.4407856,69.821808,70.1228012,70.4237944,70.7247876,..
Timor-Leste,TLS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.8583982,61.4358946,63.013391,64.6738608,66.3343306,67.9948004,69.6552702,71.31574,72.0320962,72.7484524,73.4648086,74.1811648,74.897521,75.4476278,75.9977346,76.5478414,77.0979482,77.648055,77.976532,78.305009,78.633486,..
Togo,TGO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,46.1603992,46.0876896,46.01498,46.4851234,46.9552668,47.4254102,47.8955536,48.365697,49.4899844,50.6142718,51.7385592,52.8628466,53.987134,54.4360146,54.8848952,55.3337758,55.7826564,56.231537,56.7238606,57.2161842,57.7085078,..
Togo,TGO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.519406,50.506017,50.492628,50.8805502,51.2684724,51.6563946,52.0443168,52.432239,53.6061296,54.7800202,55.9539108,57.1278014,58.301692,58.8143194,59.3269468,59.8395742,60.3522016,60.864829,61.4284818,61.9921346,62.5557874,..
Tonga,TON,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,69.139273,68.943901,68.748529,68.2441276,67.7397262,67.2353248,66.7309234,66.226522,66.4680134,66.7095048,66.9509962,67.1924876,67.433979,67.5999776,67.7659762,67.9319748,68.0979734,68.263972,68.43768,68.611388,68.785096,..
Tonga,TON,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.4407454,76.7192072,76.997669,77.1923478,77.3870266,77.5817054,77.7763842,77.971063,78.1669952,78.3629274,78.5588596,78.7547918,78.950724,79.112609,79.274494,79.436379,79.598264,79.760149,79.9847978,80.2094466,80.4340954,..
Trinidad and Tobago,TTO,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,65.5304174,65.7572732,65.984129,66.3210604,66.6579918,66.9949232,67.3318546,67.668786,68.1872994,68.7058128,69.2243262,69.7428396,70.261353,70.4558168,70.6502806,70.8447444,71.0392082,71.233672,71.4112882,71.5889044,71.7665206,..
Trinidad and Tobago,TTO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.0565126,76.5363708,77.016229,77.5185844,78.0209398,78.5232952,79.0256506,79.528006,79.8338664,80.1397268,80.4455872,80.7514476,81.057308,81.2249502,81.3925924,81.5602346,81.7278768,81.895519,82.067952,82.240385,82.412818,..
Tunisia,TUN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,75.5832142,76.0325196,76.481825,76.735472,76.989119,77.242766,77.496413,77.75006,78.142599,78.535138,78.927677,79.320216,79.712755,80.035358,80.357961,80.680564,81.003167,81.32577,81.6234484,81.9211268,82.2188052,..
Tunisia,TUN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.5653812,84.9097556,85.25413,85.493283,85.732436,85.971589,86.210742,86.449895,86.5548586,86.6598222,86.7647858,86.8697494,86.974713,87.1803038,87.3858946,87.5914854,87.7970762,88.002667,88.205891,88.409115,88.612339,..
Turkiye,TUR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,69.3126564,70.4134552,71.514254,72.105343,72.696432,73.287521,73.87861,74.469699,75.2811212,76.0925434,76.9039656,77.7153878,78.52681,79.0709472,79.6150844,80.1592216,80.7033588,81.247496,81.6030904,81.9586848,82.3142792,..
Turkiye,TUR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.7410898,82.4100874,83.079085,83.6099666,84.1408482,84.6717298,85.2026114,85.733493,86.1394472,86.5454014,86.9513556,87.3573098,87.763264,88.0894796,88.4156952,88.7419108,89.0681264,89.394342,89.5977794,89.8012168,90.0046542,..
Turkmenistan,TKM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,53.6524028,54.0008814,54.34936,54.9260028,55.5026456,56.0792884,56.6559312,57.232574,57.7363362,58.2400984,58.7438606,59.2476228,59.751385,59.9572334,60.1630818,60.3689302,60.5747786,60.780627,60.9748676,61.1691082,61.3633488,..
Turkmenistan,TKM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,70.593027,70.859985,71.126943,71.5526188,71.9782946,72.4039704,72.8296462,73.255322,73.6169716,73.9786212,74.3402708,74.7019204,75.06357,75.292915,75.52226,75.751605,75.98095,76.210295,76.4221988,76.6341026,76.8460064,..
Uganda,UGA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,25.9345734,27.5344832,29.134393,31.5162784,33.8981638,36.2800492,38.6619346,41.04382,42.8370004,44.6301808,46.4233612,48.2165416,50.009722,51.0471508,52.0845796,53.1220084,54.1594372,55.196866,55.7306296,56.2643932,56.7981568,..
Uganda,UGA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.9252862,39.1538866,40.382487,42.0990618,43.8156366,45.5322114,47.2487862,48.965361,50.7515084,52.5376558,54.3238032,56.1099506,57.896098,59.261822,60.627546,61.99327,63.358994,64.724718,65.2953982,65.8660784,66.4367586,..
Ukraine,UKR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,49.7329522,49.5839756,49.434999,49.5080082,49.5810174,49.6540266,49.7270358,49.800045,51.6705786,53.5411122,55.4116458,57.2821794,59.152713,59.5681664,59.9836198,60.3990732,60.8145266,61.22998,61.5436278,61.8572756,62.1709234,..
Ukraine,UKR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.2821782,78.3492886,78.416399,78.4574396,78.4984802,78.5395208,78.5805614,78.621602,79.456599,80.291596,81.126593,81.96159,82.796587,83.0556504,83.3147138,83.5737772,83.8328406,84.091904,84.2771114,84.4623188,84.6475262,..
United Arab Emirates,ARE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,79.0728298,79.5064444,79.940059,80.3321732,80.7242874,81.1164016,81.5085158,81.90063,82.2395424,82.5784548,82.9173672,83.2562796,83.595192,83.9059912,84.2167904,84.5275896,84.8383888,85.149188,85.3467558,85.5443236,85.7418914,..
United Arab Emirates,ARE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.8216056,83.3643468,83.907088,84.2595604,84.6120328,84.9645052,85.3169776,85.66945,86.0049838,86.3405176,86.6760514,87.0115852,87.347119,87.634559,87.921999,88.209439,88.496879,88.784319,88.9439466,89.1035742,89.2632018,..
United Kingdom,GBR,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,82.5819808,82.9607394,83.339498,83.6521016,83.9647052,84.2773088,84.5899124,84.902516,85.2317318,85.5609476,85.8901634,86.2193792,86.548595,86.6324312,86.7162674,86.8001036,86.8839398,86.967776,87.1876336,87.4074912,87.6273488,..
United Kingdom,GBR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,88.97245,89.177341,89.382232,89.5567972,89.7313624,89.9059276,90.0804928,90.255058,90.4288884,90.6027188,90.7765492,90.9503796,91.12421,91.15373,91.18325,91.21277,91.24229,91.27181,91.3491128,91.4264156,91.5037184,..
United States,USA,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,78.1627294,78.4492852,78.735841,78.9608472,79.1858534,79.4108596,79.6358658,79.860872,80.0166002,80.1723284,80.3280566,80.4837848,80.639513,80.4498074,80.2601018,80.0703962,79.8806906,79.690985,79.8041226,79.9172602,80.0303978,..
United States,USA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,86.5192786,86.6361518,86.753025,86.9143444,87.0756638,87.2369832,87.3983026,87.559622,87.6482302,87.7368384,87.8254466,87.9140548,88.002663,87.8964036,87.7901442,87.6838848,87.5776254,87.471366,87.5426358,87.6139056,87.6851754,..
Uruguay,URY,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,73.0435324,73.5087812,73.97403,74.4032082,74.8323864,75.2615646,75.6907428,76.119921,76.3293982,76.5388754,76.7483526,76.9578298,77.167307,77.3599786,77.5526502,77.7453218,77.9379934,78.130665,78.401205,78.671745,78.942285,..
Uruguay,URY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.3406032,85.4758806,85.611158,85.7443188,85.8774796,86.0106404,86.1438012,86.276962,86.4064588,86.5359556,86.6654524,86.7949492,86.924446,87.0443328,87.1642196,87.2841064,87.4039932,87.52388,87.6444586,87.7650372,87.8856158,..
Uzbekistan,UZB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,61.087561,61.3778,61.668039,62.1703906,62.6727422,63.1750938,63.6774454,64.179797,65.1232934,66.0667898,67.0102862,67.9537826,68.897279,69.4083252,69.9193714,70.4304176,70.9414638,71.45251,71.5938464,71.7351828,71.8765192,..
Uzbekistan,UZB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,74.4325364,74.7308172,75.029098,75.3953392,75.7615804,76.1278216,76.4940628,76.860304,77.404225,77.948146,78.492067,79.035988,79.579909,79.8872728,80.1946366,80.5020004,80.8093642,81.116728,81.3049222,81.4931164,81.6813106,..
Vanuatu,VUT,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,66.4885378,66.9824204,67.476303,67.8679682,68.2596334,68.6512986,69.0429638,69.434629,69.8064104,70.1781918,70.5499732,70.9217546,71.293536,71.6628554,72.0321748,72.4014942,72.7708136,73.140133,73.3594752,73.5788174,73.7981596,..
Vanuatu,VUT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,73.665652,74.21396,74.762268,75.2501762,75.7380844,76.2259926,76.7139008,77.201809,77.5959558,77.9901026,78.3842494,78.7783962,79.172543,79.4807068,79.7888706,80.0970344,80.4051982,80.713362,80.9892004,81.2650388,81.5408772,..
"Venezuela, RB",VEN,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,68.8759736,69.1497398,69.423506,69.5375936,69.6516812,69.7657688,69.8798564,69.993944,70.0475236,70.1011032,70.1546828,70.2082624,70.261842,70.0787528,69.8956636,69.7125744,69.5294852,69.346396,69.4042478,69.4620996,69.5199514,..
"Venezuela, RB",VEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.1209692,82.5623376,83.003706,83.119879,83.236052,83.352225,83.468398,83.584571,83.5956166,83.6066622,83.6177078,83.6287534,83.639799,83.4384054,83.2370118,83.0356182,82.8342246,82.632831,82.677487,82.722143,82.766799,..
Vietnam,VNM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,69.2446486,69.4303428,69.616037,69.9250424,70.2340478,70.5430532,70.8520586,71.161064,71.2354516,71.3098392,71.3842268,71.4586144,71.533002,71.596384,71.659766,71.723148,71.78653,71.849912,72.0270344,72.2041568,72.3812792,..
Vietnam,VNM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.9869714,85.1752212,85.363471,85.4815732,85.5996754,85.7177776,85.8358798,85.953982,86.0296174,86.1052528,86.1808882,86.2565236,86.332159,86.4011924,86.4702258,86.5392592,86.6082926,86.677326,86.7741292,86.8709324,86.9677356,..
"Yemen, Rep.",YEM,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,56.224615,56.977316,57.730017,58.519651,59.309285,60.098919,60.888553,61.678187,62.0873878,62.4965886,62.9057894,63.3149902,63.724191,63.7330154,63.7418398,63.7506642,63.7594886,63.768313,63.8440248,63.9197366,63.9954484,..
"Yemen, Rep.",YEM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.0430494,63.8046952,64.566341,65.3816998,66.1970586,67.0124174,67.8277762,68.643135,69.0797668,69.5163986,69.9530304,70.3896622,70.826294,70.8414742,70.8566544,70.8718346,70.8870148,70.902195,71.0063538,71.1105126,71.2146714,..
Zambia,ZMB,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,23.7248226,24.1783668,24.631911,26.221801,27.811691,29.401581,30.991471,32.581361,35.569422,38.557483,41.545544,44.533605,47.521666,48.7606302,49.9995944,51.2385586,52.4775228,53.716487,54.198783,54.681079,55.163375,..
Zambia,ZMB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.28297,32.71967,33.15637,34.940938,36.725506,38.510074,40.294642,42.07921,45.0827082,48.0862064,51.0897046,54.0932028,57.096701,59.006574,60.916447,62.82632,64.736193,66.646066,67.1459366,67.6458072,68.1456778,..
Zimbabwe,ZWE,"Survival to age 65, male (% of cohort)",SP.DYN.TO65.MA.ZS,17.5141876,16.5901768,15.666166,16.2399888,16.8138116,17.3876344,17.9614572,18.53528,23.0943718,27.6534636,32.2125554,36.7716472,41.330739,42.8977222,44.4647054,46.0316886,47.5986718,49.165655,49.6216106,50.0775662,50.5335218,..
Zimbabwe,ZWE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,27.4822988,25.8521004,24.221902,24.5983674,24.9748328,25.3512982,25.7277636,26.104229,30.695923,35.287617,39.879311,44.471005,49.062699,50.409265,51.755831,53.102397,54.448963,55.795529,56.3187742,56.8420194,57.3652646,..
,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,
Data from database: World Development Indicators,,,,,,,,,,,,,,,,,,,,,,,,,
Last Updated: 09/16/2022,,,,,,,,,,,,,,,,,,,,,,,,,
